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Abbreviations,
The abbreviations used in this thesis are as laid 
doivn in the Biochemical Journal Instruction to Authors 
(revised 1978) with the following'additions:
BHK-21/C13
HSV
PrV
p.f.u.
SDS
EDTA I 
TCA 
DMSO 
PPO.
TEHSD
HEPE3
Baby hamster kidney cells, clone 13. 
Herpes simplex virus.
Pseudorabies virus.
Plaque forming unit.
Sodium dodecyl sulphate.
Ethylene diamine tetra-acetate 
Trichloroacetic acid 
Dimethyl sulfoxide.
2,5* - diphenyloxazole
N,X,N,N, tetramethylethylene diamine.
N-2-Hydroxyethylpiperizine-N *-2-ethane. 
sulfonic acid.
DTT Dithiothreitol.
VSummary.
The inhibition of ribosomal RNA production has been 
studied in Hela cells infected with pseudorabies virus (PrV). 
This showed that both synthesis and processing of ribosomal 
RNA was affected. Processing in PrV-infected Hela cells was 
at a reduced rate but did follow a similar pattern to that 
of mock-infected cells.
The effect on synthesis of ribosomal RNA was more 
pronounced and was followed by a concomitant decrease in the 
total nucleolar area of the infected Hela cells.
Polyacrylamide gel electrophoresis of fractions from 
mock-infected and PrV-infected Hela cells showed that a 
number of virus induced polypeptides were associated with the 
nucleus, nucleolus and the nucleolar chromatin. Some of these 
polypeptides were immediate early viral gene products.
A number of viral induced polypeptides were shown to 
be associated with the nuclei and nucleoli of mock-infected 
Hela cells after incubation in vitro of isolated nuclei and 
cell extracts of both mock-infected and infected Hela cells.
The RNA polymerase activity of isolated nuclei of PrV- 
infected Hela cells was lower than that of mock-infected.
This was true both for total and for a-amanitin resistant 
activities.
The difference in RNA polymerase activity between 
mock-infected and infected Hela cells remained unchanged 
after incubation of the nuclei in the presence of the 
detergent sarkosyl. Again incubation in the presence of 
extracts of mock-infected or infected cells did not alter 
relative activities in the normal assay whereas RNA 
polymerase activity in mock-infected Hela cell nuclei was
VI
reduced after a combined exposure to infected cell extracts 
followed by treatment with sarkosyl.
This suggests that its inhibition of ribosomal RNA 
synthesis in Hela cells after infection with pseudorabies 
virus is by interference at the initiation level of the 
transcription process rather than the elongation level. It 
may be mediated by a viral-induced protein(s) associated 
with the nucleolar and nucleolar chromatin cell fractions.
vil
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CHAPTER 1. Introduction 
A - Nucleolus
1.1 Nucleolus structure
1.1.1 Nucleolus organizer regions.
Nucleolus organizer regions are specific chromosomal
sites which are responsible for the formation of the nucleolus
at the end of telophase and apparently contain the ribosomal
cistrons. This was demonstrated in plant cells (Chouinard,
1975) and animal cells (Goessens and Lepoint, 1974) by
electron microscopic studies as well as by following
nucleologenesis,in chickerythrocyte nuclei reactivated by
cell fusion (Dupoy-Coin et al,, 1976; Hernandez-Verdun and
Bouteille, 1979) and colchicine-induced micronuclei In rat
kangaroo ovary tumour cells and A9 mouse cells (Hernandez
-Verdun et al., 1979).
The nucleolar organizer has been localized in the
secondary constriction of certain metaphase chromosomes
(Heitz, 1931; Heitz&Bauer, 1933; Hsu et al., 1967; Smetana and
Busch, 1974) and has been confirmed by in situ hybridization
in man (Henderson at al., 1972; Evans et al., 1974), gibbon
(Warburton et al., 1975), kangaroo rat (Hsu et al., 1975),
Indian munjac (Perdue and Hsu, 1975) and mouse (Elsevier and
Ruddle, 1975; Henderson et ai., 1976). In situ hybridization
also reveals that the ribosomal cistrons may be detected in
chromosomal regions not displaying secondary constrictions
(Hsu et al,, 1975; Elsevier and Ruddle, 1975; Henderson et
al., 1976). In interphase nuclei in situ hyb&dization shows
the ribosomal cistrons to be localized either within the
nucleolus or at the nucleolar periphery (Perdue, 1974; Stahl
\
et al, 1976; Vagner-Capodano et al., 1977). The number and
the location of nucleolus organizer regions are specific.
In human cells, five pairs of chromosomes, 13-14-15-21-22, 
exhibit such nucleolus organizer regions (Tantravahi et al.,
1976).
Electron microscopy has led to the demonstration that 
the electron-lucid zones which Recher et al., (1969) called 
"fibrillar centres" correspond to the nucleolar organizer . 
(Goessens, 1976; Jordan and Luck, 1976; Stahl et al., 1977; 
Mirre and Stahl, 1978a; 1978b; Vagner-Capodano and Stahl, 
1980). This has been confirmed by in situ hybridization 
(Knibiehler et al., 1977).
The ultrastructure of fibrillar centres appears as 
round bodies of low electron density, surrounded by a dense 
fibrillar component (Mirre and Stahl; 1978u), which could be 
thé- bite of rDNA transcription (Lepoint and Goessens, 1978; 
Mirre and Stahl, 1978a; 1978b) and histochemical and 
autoradiographic studies have shown that it contains
DN^ and protein (Lafontaine and Lord, 1973; Ryser et al., 
1973; Goessens, 1976; Mirre and Stahl, 1978a; 1978b).
It has been shown that the fibrillar centres appear as 
euchromatin regions of chromosomes during mitosis (Goessens 
and Lepoint, 1974) or meiosis (Mirre and Stahl, 1976; 1978a; 
Jordan and Luck, 1976), At interphase, masses of condensed 
chromatin are structurally continuous with the extended 
chromatin of the fibrillar centres. The condensed nucleolar 
chromatin could correspond to the heterochromatin state of 
nucleolar chromosomes (Goessens, 1979).
1.1.2. Ultrastructure of nucleolus.
The ultrastructural morphology of the nucleolus as 
defined by electron microscopic studies is composed of electron 
-opaque fibrous material (fibrillar component), closely packed 
granules (granular component), nucleolus-associated condensed 
chromatin and low electron density fibrous material surrounded 
by, and intimately associated with the dense fibrous material, 
(see fig. 1.1.2.1).
1.1.2.1. The fibrillar component.
The fibrillar component is composed of fibrils
approximately 30-40 S in diameter (Marinozzi and Bernhard,
1963; Bernhard and Granboulan, 1968; Busch and Smetana, 1970) 
and about 200-400 8 in length (Busch and Smetana, 1970).
The fibrillar component contains 45s precursor ribosomal
RNA, as has been shown by labelling experiments, coupled with 
electron microscopy and autoradiography in various cell systems 
(Buteille et al., 1974; Fakan, 1978) and biochemical studies, 
in fractions containing nucleolar fibrillar components (Matsuura
et al., 1974; Royal and Simard, 1975),
Electron microscopy and autoradiography was also used 
to reveal the site of transcription in the nucleoli. It was 
found that after a short time of incubation in radioactive 
precursor, label appearedpredominantly in the transition regions 
between the fibrillar centres (see section 1.1.1) and the 
adjacent fibrillar component while the centre itself remained 
unlabelled (Fakan, 1971; Goessens, 1976; Lepoint and Goessens, 
1978; Mirre and Stahl, 1978a; b; c; Stahl et al., 1978).
1.1.2.2. The granular component.
The granular component contains granules 100-200 R
Figure 1.1.2,!. Hypothetical diagram of nucleolus.
f.c: fibrillar centre, f; fibrillar component,
g; granular component, p.c.: perinucleolar chromatin,
i.e.; intranucleolar chromatin, 
from Goessens, G. and Lepoint^A. (1979).
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diameter (Bernhard and Granboulan, 1968; Busch & Smetana, 1970). 
Labelling experiments revealed that the granules were labelled 
after the fibrils (Granboulan and Granboulan, 1965) which led 
to the conclusion that fibrils were the morphological precursors 
of the granules and corresponded to the processing of 45s _ 
pre-rRNA into 28s and 18s rRNA. This was later confirmed by 
other investigators (see Fakan, 1978), In addition to labelling 
experiments an early report demonstrated the morphological 
transition between nucleolar fibrils and granules (Marinozzi 
1964).
Biochemical analysis has revealed the presence of 36s 
and 32s RNA (Royal and Simard, 1975) as well as 28s RNA (Koshiba 
et al, 1971) in isolated fractions of nucleolar granular 
components in cultured CHO cells and rat liver.
1.1.2.3. Nucleolus-associated chromatin.
Chromatin structures associated with the nucleolus 
are present around(perinucleolar or withindntranucleolar )
(X»lc6
the nucleolar bodyAContain many different chromosomal 
segments as observed by the use of specific stains (Stahl 
et al., 1976).
Perinucleolar, chromatin surrounds the nucleolar body in 
a discontinuous shell of clusters of fibrils,usually composed 
of coiled fine filaments, displaying the same staining 
properties as the rest of the condensed chromatin. It often 
shows irregular extensions into the nucleoplasm, whereas the 
nucleolar body appears penetrated by chromatin stretches,to 
form the intranucleolar chromatin in continuity with 
perinucleolar chromatin (Bernhard, 1966).
The quantity of intranucleolar chromatin appears'to be 
directly related to the level of transcriptional activity of 
the nucleolus (Smetana and Busch, 1974) and modifications in 
the quantitative partition between intranucleolar and 
perinucleolar chromatin rapidly occur in parrallel with 
alterations in cell growth (Simard and Bernhard, 1967).
It has been suggested that intranucleolar chromatin 
exists simultaneously, as clumped 100 2 fibrils and dispersed 
20 2 fibrils (Unuma et al., 1968). This complex structure of 
intranucleolar chromatin was confirmed by other investigators 
(Smetana^et al., 1968 a;b;) and can probably be condidered 
to express the presence of condensed and extended chromatin 
within the nucleolus.
1.1.3. Nucleolar constituents.
1.1.3.1. DNA.
The DNA in the nucleolus consists of (a) the ribosomal 
DNA (b) the DNA coding for the nucleolus specific RNA and 
(c) the nucleolus-associated DNA for which functions have not 
yet been defined.
The ribosomal DNA contains the 18s, 5.8s and 28s rRNA 
genes and transcribed and non-transcribed spacer sequences 
(Birnstiel et al., 1971; Dawid et al., 1970). The transcriptional 
unit consists of the 18s, 5.8s and 28s rRNA genes,in that 
order from 5' to 3' (Planta and Meyerink, 1979),separated by 
transcribed spacers and is present in multiple copies per 
genome,both in procaryotes and eukaryotes,with the number of 
copies varying considerably between species. (Long and - 
Dawid, 1980).
The multiple rRNA transcriptional units are arranged 
along the DNA separated by the non-transcribed spacer sequences.
In higher eukaryotes the length of the non-transcribed spacers 
varies in size among species, although in most cases is 
comparable to the length of the transcriptional unit 
(Trendelenburg et al,, 1973).
However, in mammals, ribosomal DNA represents a very 
minor part of nucleolus-associated DNA sequences, less than 
1/0 in most cases (Attar di et al., 1965; Stambrook, 1974).
1.1.3.2. RNA.
The nucleolus contains,the first labelled and largest 
precursor ribosomal RNA molecule designated 45s pre-rRNA 
( Scherrer and Darnell, 1962 )., which is knotm to be a common 
precursor for both ribosomal RNA's (Attardi and Amaldi, 1970;
Maden, 1971), the intermediate precursors of processina and
the low molecular weight which has-been shown to be
nucleolus specific (Ro-choi and Busch, 1974) and hydrogen 
bonded to precursor rRNAs (PrestayaKo et al., 1970).
Precursor ribosomal RNA.is found in the nucleolus in 
the form of pre-ribosomal particles,bound with proteins. Two 
types of such particles found in Hela cells were 80s pre-RNP, 
containing 45 pre-rRNA and 55s pre-rRNP containing 32s pre-rRNA,
Both particles contain 5s rRNA (Warner and Soeiro, 1967;
Warner, 1974).
Kinetic studies with labelled precursors to both RNA 
and proteins,established that the 80s pre-;RNP is a precursor 
to the 55s pre-rRNP, which in turn matures to the large 
ribosomal subparticle (Warner, 1 9 7 4 ) , 8 0 s  pre-RNP may
be a processing particle since it seems to contain small
amounts of 41s,at32s and 20s pre-rRNA (Soeiro, 1968).
1.1.3.3, Proteins.
Protein molecules bind newly synthesized ribosomal RNA 
inside the nucleolus to form preribosomes. Studies on 0.4N 
sulfuric extracts of nucleoli of rat liver and Novikoff 
hepatoma cells, have revealed the presence of 95 distinct 
polypeptides on two-dimensional polyacrylamide gel 
electrophoresis (Orrick et al,, 1973; Yeoman et al., 1973). 
While 7-10 of these spots ate histones most of the polypeptides 
visualized are non-histone proteins.
Jackowski et al., (1976) have also isolated and 
analysed by two-dimensional gel electrophoresis the nucleolar 
proteins of male albino rats and identified more than 100 
components.
The proteins from animal cell pre-ribosomal particles
have been characterized in some detail. Analyses of proteins 
of 55s pre-RNP, pulse and steady state labelled,by two- 
dimensional gel electrophoresis have showh the presence of 
65 polypeptides with 30 of these found at 60s mature
ribosomal subunits (Kumar and Subramanian, 1975). Analyses 
of 80s pre-RNP particle proteins identified about 60 / 
polypeptides with 21 identified as large ribosomal subunit 
and with 10 as small ribosomal subunit proteins. The 
remaining 29 non-ribosomal proteins are probably stable and 
confined to the nucleolus (Prestayako et al., 1974).
The presence of small ribosomal subunit proteins in 
the nucleolus is also supported by fingerprint analyses of. 
tryptic digestion products of nucleolar protein (Sheperd 
and Maden, 1972). However analysis of pre-ribosomal particle 
proteins of Hela cells detected no small ribosomal subunit 
proteins on either precursor (Kuter and Rodgers, 1976) whereas 
lymphocytic mouse leukemia cells small ribosomal subunit 
proteins were detected associated with the 80s pre-RNP and 
not the 55s pre-RNP (Auger-Buendia and Longuet, 1978) .
1.1.3.4. Enzymes.
One of the most significant enzymes which is present 
in nucleoli of eukaryotic cells is DNA-dependent RNA Y' 
polymerase which is much more complex in structure,localization 
and function than its procaryote counterpart.
DNA-dependent RNA polymerase is present in eukaryotic 
cells in multiple forms as has been shown both by • .
chromatography on DEAE-sephadex (Roeder and Ruiter, 1969; 1970) 
and by the use of the specific inhibitor Or-amanitin (Lindell 
et al., 1970). Three classes of enzymes (I, II, III or A,B,C)
10
of eukaryotic DNA-dependent RNA polymerases.
Class
Micro- * 
heterogeneity
a-Amanitin-
sensitivity
Principal
intracellular
localization
Putative
function
I or A
I^or
leor
(3Eb
(a h
(Alb
(la
(AI
(Ala
Insensitive Nucleolar Ribosomal RNA 
synthesis
II or B (II q )
. .  11^
or BO 
or BI 
or BI
Sensitive to 
low concns.
(1-lOnM)
Nucleoplasmic hnRNA (mRNA?) 
sensitive
111 or C
Ills
(Cl) 
(CIT) 
or CIII^
or CITT^
Sensitive to 
high concns. 
(10-100 pM)
Nucleoplasmic. 
(cytoplasmic)
4S and 5S RNA 
synthesis.
*For species in parentheses, there is a doubt as to whether they 
are of general occurence.
(after Beebee and Butterworth, 1977).
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Table 1.1.3.2.
Subunits of calf thymus RNA polymerase Al.
Form Alb Form Ala
Subunit
Molecular
weight^ Subunit
Molecular
weight^
SAl 197 (l)b SAl 197 (1)
SA 2 125 (1) SA 2 126 (1)
SA3 51 (1) - —
SA4 44 (1) SA4 44 (1)
SA 5 25 (2) SA5 25 (2)
SA 6 15.5 (2) SA6 15.5 (2)
^Molecular weight; daltons x 10 ^
^Numbers in parentheses correspond to molar ratios^
(from Charabon,1975)
12
were analysed accordingly (see Table 1.1.3.1). Class A 
enzymes, forms Al and All have been resolved in rat liver 
and both appear to be of nucleolar origin and resistant to 
inhibition by a-amanitin. (Chesterton and Butterworth, 1971a; 
Chesterton et al., 1972; Muramatsu et al., 1975).
The Al form was further split into two chromatographically 
distinct forms Ala and Alb which differ by the presence (Ala) 
or absence (Alb) of one small (approx. 50.000 daltons) 
polypeptide (Muramatsu et al., 1975; Gissinger & Chambon,
1975; Matsui et al., 1976a) and it has been suggested that 
form All may ■' constitute the pool of "free" enzyme (Matsui 
et al., 1976b,,Kellas et al., 1977).
All the eukaryotic DNA-dependent RNA polymerases are 
macromolecular multi-subunit enzymes having molecular weights 
close to/or in excess of 500.000. In all cases, the enzymes 
consist of two high molecular weight subunits'(in excess of 
100.000) and a number of smaller subunits (less than 100,000). 
However there is no general agreement as to the precise 
subunit structure of the various enzymes. On the other hand 
immunological studies suggest that forms I and II enzymes 
are different gene products (Hildebrandt et al., 1973;
Kedinger et al., 1974) whereas fingerprinting analyses 
suggested that three small subunits may be common to all the 
enzyme forms (Buhler et al,, 1976). The subunit structure 
of Al enzyme is shown in Table 1.1.3.2.
Other enzymes which have been suggested to be localized 
in the nucleolus are an NAD synthetase (pyrophosphorylase) 
(Busch and Smetana, 1970), and a protein kinase activity 
(Kang et al., 1974).
Other enzymes which should be localized 
in the nucleolus are enzymes for the processing of ribosomal
13
RNA. Several endoribonucleases have been discovered in nucleoli 
(Prestayako et al., 1973; Mirrault and Scherrer,1972; Kwan 
1975; Hall et al., 1977), but the most likely candidate is 
an endoribonuclease, named RNAse DIX,which is associated 
with the pre-ribosomal particles and is double stranded RNA 
specific (Grummt et al., 1979),
14
1.2. Nucleolar function.
The major function of the nucleolus is the formationdf . 
precursors of the ribosomes,which pass into the cytoplasm to form 
the mature ribosomes. This involves the synthesis of ribosomal 
RNA,by RNA polymerase I (Weinman & Roeder, 1974) and its 
processing in several steps to yield mature cytoplasmic RNA 
(Perry, 1976). Ribosomal proteins are synthesized in the 
cytoplasm (Craig & Perry, 1971; Wu & Warner, 1971), transported 
to the nucleolus (Warner,.1974) and assembled on a precursor
to ribosomal RNA (Warner, 1974; Maden et al., 1974).
1.2.1. Transcription.
The size of the primary transcript of ribosomal DNA in 
mammals has a sedimentation coefficient of 45s with a mol. 
weight of 4.1 x 10^ daltons and in lower eukaryotes of 36s 
to 38s with a mol, weight of 2.6 to 2. 8 x 10^ daltons 
respectively. (Loaning et al., 1969; Wellauer & Dawid, 1975).
Regulation in the rate of transcription of ribosomal
DNA might involve changes in already existing enzymes rather 
than in absolute numbers of enzyme molecules ‘(Schmid and 
Sekeris, 1975; Franze-Fernantez and Fontanive-Sanguesa 1975).
Thus regulation of ribosomal RNArsynthèsis^might be template 
-mediated rhther.i'than' RNApelymerase-mediâted;':" Indeëdp.pMcKnight 
& Mj-llér < 1976)--have 'suggested^^thatihansincreasrer-'in the rate 
of rRNA synthesis occurs by the progressive activation of 
additional transcription units. Thus the amounts of template 
bound RNA polymerase I probably vary with metabolic state.
This was suggested by the assay of Hela cell nuclei isolated 
from cells in a variety of metabolic conditions. Assays were 
carried out in the presence of the anionic detergent sarkosyl
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(Chesterton et al., 1975). Further evidence comes from RNA 
3 '-end labelling after oestradioltreatment of chick oviduct 
(Cox, 1976).
The existence of separate free and bound pools of RNA 
polymerase I molecules was shown in experiments using 
exogenous added poly (dA-dT) templates in the presence of 
actinomycin (Lampert & Feigelson, 1974; Yn, 1974; Grummt et al., 
1976.)
Nonetheless ribosomal RNA synthesis does depend on 
continuous protein synthesis (Lampert & Feigelson 1974;
Grummt et al., 1976) which is presumed to be mediated either by a 
rapidly turning-over factor (Lampert & Feigelson, 197 4 
Chesterton et al., 1975) or by the intracellular concentration: 
of GTP and ATP (Grummt and Grummt, 1976).
Electron-microscopic evidence together with
u.V.-irradiation studies on ribosomal cistron transcription, 
have suggested that each ribosomal gene has its own promoter 
in contrast with the model of Perry et al., (1970), proposing 
a single promoter region for all the ribosomal genes linked 
in tandem. This conclusion is suggested by the frequent 
appearance of putative polymerases in transcribed spacer 
regions (Scheer et al., 1976; Hackett and Sauerbier, 1975).
1.2.2. Processing.
The primary transcript of ribosomal DNA is further 
subjected to processing to yield mature rRNA. Processing of 
the primary transcript involves endonucleolytic cleavages, 
possibly carried out by specific endonucleases assisted by 
npcleotide modifications, the bound proteins and
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the double-strended regions of pre-rRNA.
The possibility exists that at least in some eukaryotic 
organisms and cells,processing may precede the completion and 
accumulation of the primary pre-rRNA. The evidence for this 
is that rapidly labelled RNA molecules can be isolated,which 
are larger than the established primary pre-rRNA for the 
respective organisms (Hidvegi et al., 1971) and that larger 
than primary pre-rRNA molecules are synthesized in isolated 
nuclei by an a-amanitin resistant RNA polymerase (Gaston and 
Jones, 1972; Grummt et al., 1975) and finally by the application 
of the gene spreading technique to various eukaryotic organisms 
(Trendelenburg et al., 1973; Trendelenburg, 1974).
The pre-rRNA processing pathways have been intensively 
studied in many different eukaryotes and basic similarities 
have been shown to exist, as illustrated in Fig. 1.2.2.1 
(Hadjolov and Nikolaev, 1977).
Three distinct steps may be outlined in primary pre-rRNA 
maturation. The first step involves an endonucleolytic 
cleavage to remove the external transcribed spacer, the second 
step involves an endonucleolytic cleavage of the intermediate 
pre-rRNA to produce the precursor to the ribosomal 28s rRNA 
and in some cases directly the mature 18s rRNA and the third 
step,which is rather complex and slower, involves an 
endonuclease attack to form the 28s rRNA and 5.8s rRNA and a 
final trimming of 28s and 18s pre-rRNA molecules (Wellauer 
and Dawid, 1973). Four specific endonucleolytic events have 
been shown to occur in mammalian cells (Wellauer and Dawid,
1973; Wellauer et al., 1974) but the order in which cleavages 
occur may vary. It has been suggested that double-stranded 
regions in pre-rRNA may play a role in defining the correct
17
0,^6
3'
cats
CMS)
1$S
C3os)
1.SC
(a) Xenopus laevis 
ot b e d
5' i I I I
i.74
C2SS)
(b) Hela cells
("24,) 33 ^  C415^
C-155) I
\
(c) L cells
‘igure 1.2.2.1 Scheme of maturation of primary pre-rRMA
in Xenopus haevis,Hela cells.and L cells. 
a,b,c and d denote cleavage sites and the order 
of endoribonuclease attack.
(from Hadjolov and Nikolaev,1977)
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processing sites (Gotoh et al., 1974; Snyder etfal., 1971). 
Similarly, the association of proteins with pre-rRNA may be of 
critical importance throughout the entire maturation process 
(Craig and Perry, 1970; Maden, 1971).
Several endoribonucleases have been reported (see section 
1.1.3.4) as possible candidates for the cleavage of 45s pre-rRNA 
but direct evidence for their involvement has not yet been 
obtained.
Two types of nucleotide modification occur in ribosomal 
RNA, one is the conversion of uridine to pseudouridine 
(5-ribosyluracil), which is present in both 28s and 18s rRNA 
and constitutes about 0.5% to 5% of the uridine residues 
(Attardi and Amaldi, 1970) and the other is méthylation, which 
takes place either on the 2' position of the ribose moiety 
or,on the nucleotide base and most of these occur at the level 
of the 45s primary pre-rRNA molecules and along sequences 
corresponding to mature 28s rRNA, 18s rRNA and 5.8s rRNA 
(Maden et al., 1974). Both modifications occur during or 
after transcription and their possible function in processing 
is as yet unclear.
That méthylation plays a role in ensuring correct 
processing has been assumed by the occurence of ribose and 
base méthylations at specific sites along the primary pre-rRNA 
(Maden et al., 1974) and is supported by the finding that 
methionine starvation of Hela cells results in changes in 
the correct processing of the pre-rRNA (Vaughan et al., 1967),
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B. Herpesviruses.
1.3. Introduction.
The herpesviruses are large eucaryotic viruses,with linear 
double-stranded DNA genomes of more than 80 x 10^ mol. wt., 
which are replicated in the nucleus of infected cells, 
assembled into lOOnm diameter icosahedral capsids composed of 
152 prismatic capsomeres which are enclosed in glycoprotein 
and lipid (ether sensitive) envelopes to give the normaly 
infectious extracellular form of the virus (Wildy, 1972;
Fenner, 1976).
Herpesviruses have been observed in a wide variety of 
hosts as diverse as fungi, oysters, fish (e.g. channel 
catfish, rainbow trout),-amphibians and reptiles (e.g. Lucke 
virus of frog),birds (including Marek's disease virus of 
chickens) and numerous mammals including monkeys, apes and 
man (Nahmias, 1972). A single host may be infected .by several 
distinct herpesviruses each of which can produce different 
pathological consequences. For example,humans are hosts to 
at least five herpesviruses (HSV-1, HSV-2, cytomegalovirus, 
Epstein-Barr virus and varicella-zoster virus) whose 
pathology ranges from mild skin diseases to severe, frequently 
fatal lymphomas and leukaemias.
Although 70 or more viruses (Table 1.3.1) are tentatively 
included in the herpesvirus group, criteria for their 
inclusion varies from a brief morphologic description (virus 
obtained from snake venom, oysters and fungi) to detailed 
antigenic, structural, biochemical, and genetic characterization 
(e.g. HSV-1, HSV-2).
Because herpesviruses constitute a widely diverse group,
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Table 1.3.1. Provisional Labels, Common names and Properties of 
the DNA of Herpesviruses.
Provisional label^
G+C MW
Common name Abbreviation (moles %) (xlO
67 97-99
-6
Human herpesvirus 1 Herpes simplex . HSV-1
type 1
Human herpesvirus 2 Herpes simplex HSV-2
type 2
Human herpesvirus 3 Varicella-zoster
virus
Human herpesvirus 4 Epstein-Barr
virus
EBV
Human herpesvirus 5 .Cytomegalovirus CMV
Ceropithecid B virus
herpesvirus 1
Ceropithecid 
herpesvirus 2
Ceropithecid 
herpesvirus 3
SA 6 
SA 8
Cebid herpesvirus 1 Herpesvirus
tamarinusj 
herpesvirus 
platyrrhini; 
marmoset 
herpesvirus
Cebid herpesvirus 2 Herpesvirus
saimiri
: .1
Cebid herpesvirus 3 Spider-monkey
herpesvirus
Callitrichid 
herpesvirus 1
Marmoset
herpesvirus
Tupaiid herpesvirus 1 Tree shrew
herpesvirus
Canine herpesvirus 1 Canine
herpesvirus
Feline herpesvirus 1 Feline
rhinotracheitis
Equid herpesvirus 1 Equine abortion EAV
virus,equine 
rhinopneumonitis 
virus
69
46
59
56-57
51
67
50 
72 ■
66
33
46
57
99
100
84-94
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Continued
Table 1.3.1. Provisional labels. Common Names and properties of 
the DNA of Herpesviruses.
Provisional label^ Common nams- Abbreviation. Q±g— JM.
(moles .%! (xlQ
Equid herpesvirus 2 Slowly growing 58
cytomegalo- 
tÿpê viruses
Equid herpesvirus 3 Coital-exanthe- EAV 56
ma virus
Bovid herpesvirus 1 Infectious 71-72
bovine
rhinotracheitis
virus
Bovid herpesvirus 2 Bovine mammalitis 64 82
virus
Bovid herpesvirus 3 Wildebeest
herpesvirus, 
malignant 
cattarrhal fever 
vi rus
Bovid herpesvirus 4 Herpesvirus from
sheep pulmonary 
adenomatosis
Pig herpesvirus 1 Pseudorabies BrV 72 9 5
virus
Pig herpesvirus 2 Inclusion-body
rhinitis virus, 
pig cyto­
megalovirus
Murid herpesvirus 1 Mouse cyto- 59 132
megalo-virus 
from Mus
Murid herpesvirus 2 Rat cytomegalo­
virus from 
Rattus
Sciruid herpesvirusl Cytomegalovirus
from European 
ground squirrel
Caviid herpesvirusl Guinea-pig 57
cytomegalovirus
Lagomorph Rabbit herpesvirus
herpesvirus 1
Phasianid
herpesvirus 1 Infectious 45
laryngotracheiti s
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Continued
Table 1.3.1. Provisional labels. Common Names and Properties of
the DNA of Herpesviruses.
Provisional Label^ Common Name Abbreviation G+C MW
(moles %) (xlO
Phasianid . Mareks disease MDV 46 103
herpesvirus 2 virus
Turkey herpesvirus 1 Turkey herpesvirus 46
Anatid herpesvirus 1 Duck-plague
herpesvirus
Pigeon herpesvirus 1 Pigeon
herpesvirus
Cormorant Cormorant
herpesvirus 1 herpesvirus
Iguana herpesvirus 1 Iguana herpesvirus
Ranid herpesvirus 1 Lucke virus 44-45
Ranid herpesvirus 2 Frog Virus 4 56
Catfish Catfish 56
herpesvirus 1 herpesvirus
( from .Roizman, 1977)
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Honess and Watson (1977) investigated measures of similarity 
and difference between the putative members of the herpesvirus 
group at the level of the host and disease, the gross 
properties of size, sequence arrangement and base composition 
of the genome as well as the number and properties of some 
gene products. Their conclusions for the characteristics 
which confer the essential unity of the family are: the 
common possesion of DNA with single strand interruptions and 
a mol. wt. >80 X 10^, a major capsid polypeptide mol. wt. 
>140.000, a virus-specific non-structural DNA polymerase and 
a propensity for persistence in the absence of overt disease.
The International Commitee on Taxonomy of Viruses have 
classified herpesviruses as a separate family,namely the 
Herpetoviridae (Fenner, 1976). The diversity of herpesviruses 
has caused problems in the sub-division of Herpetoviridae 
into genera (Fenner, 1976).
Recently Yeo et al., (1981) have reported the 
identification of the polypeptides involved in the cross­
reacting antigens of five herpesviruses.' The predominant 
polypeptide,corresponded to the major DNA binding protein.
They suggested that the DNA binding protein will be useful 
for the classification of the group, that the major capsid 
protein may help identify some cross-relationships among 
members of the group, and that the glycoproteins will define 
the subgroups of the family.
✓
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1.4. The herpesvirion.
1.4.1. Structural components.
The virion consists of 4 major structural components.
The core,which is surroundedby the capsid, the tegument and 
the envelope. These are discussed below.
1.4.1.1. The Core.
The core is the innermost structural component of the 
virion and appears in thin sections of virions as an electron 
dense ring surrounding an electron-translucent centre. 
Evidence that the core contains DNA comes from Epstein (1962), 
who demonstrated the DNAse sensitivity of the central region 
of the virion; later Furlong et al., (1972) showed that the 
DNA is contained in the electron-dense ring, by treating 
glutaraldehyde fixed, uranyl-acetate stained thin sections 
with EDTA. EDTA selectively removed uranyl ions bound to DNA 
Although there is no direct evidence on the composition 
of the core, it probably contains proteins and polyamines 
(Roizman, 1977). Possible candidates for the core proteins 
might be the four proteins which have been demonstrated to 
bind tightly but non-covalently to highly purified HSV DNA 
in vitro (Hyman, 1980).
1.4.1.2. The capsid.
The capsid surrounds the core and appears in thin 
sections as a moderately electron dense hexagon or ring,
separated from the core by an electron translucent shell 
(Roizman, 1977)
The capsid consists of capsomeres arranged in 2—, 3— 
and 5- fold symmetry and from the geometrical structure of
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the capsid it has been deduced that it consists of 152 
capsomeres arranged in the form of an icosadeltahedran 
(Wildy et al., 1960). The region between the capsid and the 
core is called the pericore and its nature is unknown.
1.4.1.3, The tecrument.
The tegument is located between the capsid and the 
envelope (Roizman & Furlong, 1974) and in thin sections appears 
as a layer of amorphous material and in negatively stained 
virions as a fibrous structure (Roizman, 1977).
1.4.1.4. The envelope.
The virion is surrounded by the envelope, a trilaminar 
membrane with spikes projecting from its outer surface (Fong 
et al,, 1973). It is constituted of glycoproteins, glycolipids 
and lipids (Morgan et al.i 1954). Envelopes are formed during 
the passage of the virionthrough the nuclear membrane as well 
as from Golgi apparatus membranes, endoplasmic reticulum 
and plasma membranes. (Darlington & Moss, 1968; Schwartz 
& Roizman, 1969; 1969a; Epstein, 1962).
The role of the envelope is not yet clear^ although it 
is believed to facilitate adsorpion (Holmes & Watson, 1962; 
Abodeely et al., 1971) or to give stability to the virus 
outside the cell (Spring & Roizman, 1968).
1.4.2. ' Chemical constituents.
1.4.2.1. DNA.
The genome of herpesviruses consists of a linear, 
double-stranded DNA molecule. Linearity has been confirmed 
by electron microscopic studies (Becker et al., 1968;
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GrafStrom et al., 1975; Wadsworth et al., 1975).
The mol. wt. of the DNA of pseudorabies virus, one of 
the herpesviruses, is about 90 to 95x10^ daltons (Stevely,
1977) and generally the size of herpeviruses DNA varies from 
80 to 150 X  10^ daltons.
The DNA molecule of a number of herpesviruses is 
fragmented upon dénaturation with alkali (Kieff et al., 1971; 
Lee et al., 1971; Nonoyama et al., 1972). A number of possible 
explanations have been suggested from the presence of 
ribonucleotides to single strand nicks or gaps. However the, 
evidence most strongly suggests that fragmentation is due to 
the presence of gaps in the HSV DNA (Roizman, B., 1977, The 
Herpesviruses) . The presence of nicks and gaps at random 
sites along the DNA molecule has also been reported to be the 
cause for the fragmentation of pseudorabies virus DNA (Ben 
Porat et al., 1979).
The base composition of herpesvirus DNAs varies, ranging 
from 33% to 74% G+C (Fenner, 1976). Pseudorabies virus DNA 
has a G+C content of 72% G+C (Ben-Porat & Kaplan, 1962; Russell 
& Crawford, 1963).
Herpes simplex and pseudorabies virus DNA consist of 
two unequal regions, the long (L) and the short (S) unique 
regions. L and S herpes simplex unique regions are flanked 
by terminally redundant sequences (Grafston et al., 1974)and 
their internal inverted repeats (Sheldrick & Berthelot, 1974; 
Wadsworth et al., 1975) whereas inpseudorabies virus this is 
true for the short unique region only and not the long (Stevely 
1977; Ben-Porat et al., 1979).
Four possible genomic arrangements could result from
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internal recombinations between the redundant sequences in 
herpes simplex virus DNA, and analysis of the HSV-1 genome by 
a variety of methods has proved that they are present in 
approximately equal amounts within a population of DNA 
molecules. (Hayward et al., 1975; Clements et al., 1976;
Delius and Clements, 1976; Wilkie & Cortini 1976). A similar 
sequence of organisation of the DNA have been reported for a 
number of other herpesviruses as well (Buchman and Roizman,
1978; Bornkam et al., 1980; Westrate et al., 1980;
Chousterman et al; 1979).
1.4.2.2. Structural proteins.
Structural proteins which constitute the main components 
of the virion along with DNA, have been analyzed in polyacrylamide 
gels containing dodecylsulfate. Herpes simplex purified 
virions contain 33 polypeptides and range in molecular weight 
from 25.000 to approximately 280.000 daltons (Spear and Roizman, 
1972). Enveloped pseudorabies virus particles contain at least 
20 polypeptides and range in molecular weights between 20.000 
to 155.000 daltons (Stevely^1975).
Analyses of the structural polypeptides of other 
herpesviruses showed that they are as complex as herpes 
simplex and pseudorabies virus. (Perdue et al., 1974; Dolyniuk, 
et al., 1976; Sarov and Abady, 1975).
1.4.2.3. Other Components.
Herpesviruses contain lipids and the polyamines spermine
and spermidine. Spermine is believed to be localized in the
core and to be involved with the neutralization of DNA-phosphate
viral groups (Gibson & Roizman, 1971; 1973), whereas spermidine 
wàsasuggested to be associated with the envelope since it was
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removed after disruption of the viral envelope with a non-ionic 
detergent and urea (Gibson & Roizman 1973). Very little is 
known about the lipids of the herpesvirion but it was 
suggested that they are essential .for infectivity of the 
mature virions and are contained in the envelope (Spring & 
Roizman, 1958) ,
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1,5. The reproductive cycle of Herpesviruses.
1.5.1. Initiation of infection.
Only the enveloped nucleocapsids could initiate infection 
(Nii et al.', 1968; Ames and Dubin, . 1960) whereas naked 
nucleocapsids can not (Stein et ah, 1970; Rubenstein & Kaplan 
1975; Rubenstein et ah, 1972). However viral DNA rendered 
free of proteins is infectious (Sheldrick et al., 1973).
Infection begins by the adsorption of the viral enveloped 
nucleocapsids by the host cell and is slow (Roizman & Furlong, 
1974). Penetration follows which could be either by, 
phagocytosis (Dales & Silverberg, 1969) or by fusion of the 
viral envelope with the plasma membrane (Morgan et al., 1968;
Zee and Talens, 1972).
%Once inside the cytoplasm the capsid dis agregates and 
the viral DNA-protein complex is transported into the nucleus 
(Hochberg and Becker, 1968).
1.5.2. Transcription of the viral DNA.
The first event in the herpesvirus reproductive cycle 
is the transcription of the viral DNA, which takes place in 
the nucleus (Wagner & Roizman, 1969; 1969a) and is carried 
out by the host DNA dependent RNA polymerase II( Preston and 
Newton, 1976; Costanzo et al., 1977; Ben-Ze«y & Becker, 1977), 
Viral RNA is processed by cleavage, méthylation, adénylation 
and capping almost in the same way as cellular mRNA (Bartkoski 
and Roizman, 1976; 1978; Moss et al,, 1977; Bachenheimer and 
Roizman, 1^72; Stringer et al.,1977).
Viral mRNA is classified,according to the time of 
synthesis in the infected cells. Immediate early mRNAs are 
synthesized very early after infection and accumulate when protein
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synthesis is inhibited,early mRNAs are synthesized after the 
initial synthesis of virus specified proteins but before 
viral DNA synthesis and late mRNAs are synthesized after 
viral DNA synthesis (Kozak & Roizman, 1974; Swanstrom &
Wagner, 1974; Swanstrom et al., 1975).
1,5.3. Synthesis of viral proteins.
Protein synthesis in herpesviruses is regulated and
different polypeptides are synthesized at different times
after infection. First attempts^to categorize the timing of 
herpesviruses protein synthesis, succesfully demonstrated the 
presence of an immediate early class of proteins which 
correspond to the immediate early mRNAs described above and 
are made soon after the release of a cycloheximide block in 
pseudorabies virus infected cells (Rakusanova. et al., 1971; 
Ben-Porat et al., 1974). Using the same type of treatment 
this was also found to be true in HSV-1 infected cells and 
allowed the classification of viral polypeptides into three 
groups a,#, and ^  polypeptides, contained the major virus 
structurolpolypeptides,while (X andffwere made up from both 
structural and non-structural proteins (Honess & Roizman, 
1974). Further work of Honess and Roizman (1975) led to a 
model of sequential ordering and coordinate regulation, where a 
polypeptide(s) are required to switch-on è polypeptides,which 
in turn are required to switch-off (X polypeptides,with a 
similar scheme for & and ^ polypeptides.
Viral proteins structural and non-structural may be 
phosphorylated (Pereira, et al., 1977; Marsden et al, 1978; 
Bookout and Levy, 1980) or glycosylated (Kaplan and Ben-Porat, 
1976.)
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1.5.4. Synthesis of viral DNA.
viral DNA synthesis requires de novo protein synthesis 
but-once initiated, viral DNA synthesis continues in the 
absence of concomitant protein synthesis (Cheng et al., 1975; 
Roizman & Roane, 1954). Many herpesviruses code for their 
own DNA polymerase (Allen et al., 1977; Miller & Rapp, 1977; 
Muller et al., 1977). HSV - DNA synthesis is suggested to be 
promoted by an RNA initiator (Mulier .et-ial., 1980).
Pseudorabies W.&:us DNA is known to be synthesized in 
the form of cbncatamers- (Jean & Ben-Porat, 1975; Ben-Porat 
& Veach, 1980; Ladin et al., 1980).
1.5.5. Assembly and release.
Assembly of the mature macromolecules occurs in the 
nucleus (Roizman & Furlong, 1974). It has been suggested 
that the capsid proteins are assembled first into an empty 
shell, into which DNA is encapsidated (Ladin, 1980) and that 
DNA is inserted into capsid without a preformed core (Perdue 
et al., 1976) ,
Viral particles acquire their envelopes by budding 
through the inner nuclear membrane or other sites and are 
released by a process of reverse phagosytosis (Morgan et al., 
1959; Nii et al., 1968; Katsumoto et al., 1981).
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1.6. Changes in cell structure and function ,
1,6.1. Introduction.
Infection of a host cell by a herpesvirus results in 
productive infection or in transformation of the cell or in 
abortive infection leading to virus latency. Available data 
indicate that the consequence of productive infection is cell 
death (Roizman, 1972), which follows gross alterations in 
cell morphology and in the structure of cellular organelles 
accompanied by drastic alterations in host DNA, protein and 
RNA synthesis.
1X6.2. Structural changes.
Infection of cells.with a herpesvirus results in 
changes in shape and behaviour. Thus the cells may round up 
and lose contact with neighbours, they may clamp together, 
or fuse into multinucleated giant cells (Roizman, 1962; 
Darlington & Granoff, 1973; Roizman & Furlong, 1974).
■ Alterations in the cell structure involve the 
characteristic displacement and condensation of the chromatin 
near the nuclear membrane (Smith and de Harven, 1973), the 
thickening of nuclear membrane areas (Schwartz & Roizman, 
1959; Tevethia et al., 1972), and alterations in nucleolar 
structure and size which consist of the segregation of 
nucleolar components, aggregation into more compact and 
electron dense masses, size reduction to the point of being 
reduced to small fragments (Sirtori & Bosisio-Bestetti, 1967) 
and the formation of intranuclear inclusion bodies (Love and 
Wildy, 1963; Smith & De Harven, 1973),
Changes in the cytoplasm involve the destruction of
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the cytoskeleton (Schlehofer et al., 1979; Katsumoto et al.,
1981), suggested by the interaction of herpesviruses with the 
microtubules and the lack of a distinct separating surface 
of the cell with the substratum. Further alterations in the 
cytoplasm consist of the appearance of patches of altered 
membranes, an increase in the frequency of microvilli 
(Roizman, 1977) as well as an increased stability of the 
cellular membrane of HSV-1 infected Hep-2 cells compared to 
uninfected (Schlehofer et al., 1979).
1.5.3. Effects of infection in macromolecular synthesis.
1.6.3.1. DNA.
Inhibition of host DNA synthesis has been observed with
a number of herpesviruses (Kaplan & Ben-Porat,~ 1963; Roizman
& Roane, 1964; O'Callahan, et al., 1968; Nonoyama & Pagano,
1972; Gergely et al., 1971), and this inhibition coincides 
c , ,
with the deline in the activity of cellular DNA polymerase cc 
(Muiier et al., 1977), which is thought to be the DNA 
replication enzyme (Bollum, 1975). The mechanism by which 
DNA synthesis is inhibited is not clear, however in HSV-2 
infected cells, DNA synthesis was inhibited following infection 
with UV-irradiated virus(Fenwick and ,'Talker, 1978).
1.6.3.2. Protein.
Infection of animal cells with a herpesvirus results 
in characteristic changes in the rate of amino acid incorporation 
(Ben-Porat et al., 1971; Honess & Roizman, 1973; Powell and 
Courtney, 1975). This includes a decrease early in infection, 
due to a decrease in synthesis of host cell proteins,followed 
by an increase in the overall rate,as viral protein synthesis
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becomes significant and finallyTirreversibly declines (Ejercito 
et al., 1968). The decrease in the rate of amino acid 
incorporation refirects a concomitant decrease in the rate of 
protein synthesis (Silverstein & Engelhardt, 1979). The 
time course of the inhibition of host protein synthesis depends 
upon the particular virus and the permisiveness of the given 
cell lih.e. It has been suggested that the inhibition of 
host protein synthesis is mediated by a protein synthesized 
early after infection (Lewis et al., 1969; Ben-Porat et al., 
1971; Lewin, 1975), however in HSV-2 infected Vero cells 
inhibition occured even after infection was carried out with 
u.v,-irradiated virus (Fenwick & Walker, 1978),
Stringer et al., (1977) showed that host mRNA continues 
to enter polysomes even at late times after infection and this 
led to the hypothesis of polysome-like structures being 
present but not functioning, pr^  poorly functioning’ in 
HSV-infected cells (Silverstein & Engelhardt, 1979),which 
suggests that a translational . control mechanism operates to 
selectively supress host protein synthesis.
The mechanism by which herpesviruses inhibit host 
protein synthesis is not clear and a number of possibilities 
are currently under investigation.
1.6.3.3. RNA.
Numerous authors but notably Roizman et al., (1965),
Hay et al., (1966) have reported that in cells infected with HSV 
the rate.of synthesis declines early after infection,
levels off from about three to eight hours after infection 
and subsequently slowly and irreversibly declines. It was 
found by them that incorporation of radioactivity into
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nuclear RNA dropped to 25% of the uninfected control by seven 
hours after infection and that at 4.5 hours after infection 
there was virtually no radioactivity incorporated into 18s 
and 28s rRNA whereas an appreciable amount of RNA synthesized 
at that time had a high mol. wt. >32s) and a significant 
fraction of this,sedimented at 45s.
It has been demonstrated that 45s RNA synthesized in 
infected cells is methylated and this méthylation occurs at 
a time when processing into 28s and 18s rRNA is virtually 
absent (Roizman et al., 1970).
To determine whether 45 r ENA accumulates or is processed
ab arrantly, Roizman et al., (1970) carried out an experiment
3in which they pulsed infected cells briefly with H-uridine 
and chased following addition of actinomycin. The results 
of this experiment showed the following;
(i) The extract of infected cells pulsed with uridine 
but not chased, yielded 27.000 cpm, sedimenting in the region 
corresponding to 45s.
(ii) RNA pulsed and chased with actinomycin yielded 
4700 cpm in the 45s region; however there was no increase in 
the radioactivity of the 18s and 28s RNA.
(iii) In the uninfected control cells, about 654to 
70% of the original radioactivity was recovered in 45s RNA 
after the pulse was "chased" out, with a concomitant increase 
in radioactivity in the 32s to 28s RNA region and also the 
appearance of radioactivity in the 18s rRNA.
The results of this experiment have been interpreted 
as indicating that the abortive processing of .the 45s rRNA 
in the infected cell nucleus results in its degradation into
oligonucleotides sedimenting with S values at less than 18s.
The inhibition of host mRNA synthesis is more rapid
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than that of the overall synthesis of RNA (Roizman et al., 
1965; Wagner & Roizman, 1969) but host mRNAs are still 
synthesized even at late times after infection (Rakusanova 
et al., 1972; Stringed et al., 1977), so it seems that host 
mRNA synthesis is not inhibited completely.
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CHAPTER 2. Materials and Methods,
2.1. Materials.
2.1.1. Biological Materials.
2.1.1.1 Tissue culture cells.
The monolayer adapted human epithelium cell line derived 
from a cervical carcinoma (Gey et al., 1952) and known as 
Hela cells was used in this study.
2.1.1.2. Virus.
Pig Herpesvirus 1 (pseudorabies virus, PrV) was 
originally derived from a stock preparation (Kaplan and 
Vatter, 1959) and has subsequently been plaque-purified 
three times. The virus stock ,is prepared by growth in baby 
hamster kidney cells ( BHK cells) (Chantier and Stevely, 1973-) .
2.1.2. Radiochemicals.
All radioactive compounds were obtained from the 
Radiochemical Centre, Amersham, Bucks.
(5,5 - ^H) uridine 47 Ci/mmol.
Sulphur - 35 970 Ci/mmol.
(6 - ^H) thymidine 20 Ci/mmol.
L -(U - ^^G) Amino acid mixture 58 mCi/mAtom.
(5,5 - ^H) uridine 5'triphosphate 41 Ci/mmol.
2.1.3. Chemicals.
Calf serum Bio-Cult Lab. Ltd, SCOTLAND.
Amino acids " " " "
vitamins " " " "
Amino acids without L-methionine " " " "
and L-glutamine
Bromophenol Blue Koch Light Lab. Ltd, ENGLAND
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2-mercaptoethanol Koch Light Lab. Ltd, ENGLAND
NNNN* tetramethylethylene .diamine " 
( TEMED'
Trichloroacetic acid "
Polyoxyethylene sorbitan "
mono-oleate (Tween 80
2,5 diphenyloxazole (PPG) 
Toluene (analar grade) 
Dithiothreitol (DTT)
Coomassie' Brilliant Blue G250
" R250
Sodium Deoxycholate
Uridine
Heparin
Glacial Acetic acid 
Trizma base 
Cytidine 
Cycloheximide
Sigma Chemical Co., ENGLAND
N ‘-2-ethanesulphonic Acid 
(HEPES)
N-Lauroil Sarcosine, sodium salt 
Microccocal Nuclease 
Dimethyl Sulfoxide (DMSG) 
Deoxyribonuclease I 
a-amanitin
Molecular weight standards 
Bovine serum albumin, trgpsin 
inhibitor, RNA polymerase 
L-methionine 
Guanidinium chloride 
Acrylamide
Boehringer-Manheim, NEST GERMAN
BDH Chemicals Ltd, ENGLAND
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NN'-methylene-bis-acrylamide
Nonidet P40
Ammonium persufate
Folin and GioKalteu's phenol_ 
reagent
Ampholines
BDH Chemicals Ltd, ENGLAND
pH 5 to 7 LKB Ltd, SWEDEN
pH 7 to 10 It tt It
pH 3.5 to 10 tt tt ' It
pH 3.5 to 5 II II tt
pH 9 to 11 tt tt It
triphosphate. P-L Chemicals Ltd
sodium
Cytidine 5 *-triphosphate 
sodium
Uridine 5'-triphosphate 
sodium
Adenosine 5 *-triphosphate 
sodium
Depex mounting medium
Ethylene diacrylate
Vfhatman No 1 (2.5cm diameter)
Whatman GF/C glass fibre 
discs (2.5cm diameter)
Whatman 3MM chromatography 
paper
Microscope slides
Microscope glass coverslips
BA 85 filters, 25mm diameter,
0.45pm pore size
Kodak X-omat H X-ray film 
Kodak DX-80 developer
Kodak FX-40 X-ray liquid 
fixer
Kodak NS-80 X-ray film 
Kodirex KD 54T X-ray film
SEARLE Bucks, ENGLAND 
Monomer-Polymer Lab., USA 
Whatman Ltd, ENGLAND
Chance propper Ltd, ENGLAND
II II II ■ II
Schleicher and Schull WEST GERMANY 
Kodak Ltd, ENGLAND
n It It
It It It
II It tt
tt It It
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MEM amino acids (xlOO) Gibco Europe Ltd., SCOTLAND
MEM amino acids minus " " " "
methionine (xlOO)
Newborn calf serum " ” ” "
(Mycoplasma screened)
MEM vitamins (xlOO)
(Glasgow modification) " *' " '*
"Chloros” Industrial Durham Chemicals Distributors Ltd ENGLAND 
grade!
Eaglets medium-'.
(Glasgow modification) Flow Lab., SCOTLAND
Giemsa stain Gurr, ENGLAND
Penici^in Glaxo Lab Ltd., ENGLAND
Strepomycin ’* " " "
Trypsin Difco Lab,, USA
Absolute Alcohol, James Burrough's Ltd, ENGLAND
Analar
2.1.4, Standard solutions.
2.1.4.1 Cell culture media.
I. Ec, Medium for Hela cells.
Dist. ^20 450ml
IF 50ml
NaHCOg 20ml
Penicillin/streptomycin 5ml 
Newborn calf serum 50ml
Added in the order shown.
II. EC-Met, Methionine free medium.
BSS 450ml
ES10 (-Met) 50ml
NaHCOg 20ml
Penicillin/streptomycin 5ml 
Calf serum 50ml
ESIO was used with the normal methionine content as well.
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Table 2.1.4.1. M.E.M. amino acid formulation.
mcr/litre
L-arginine. 126.40
L-cystine 24.00
L-glutamine 292.00
L-histidine HCl 38.30
L-isoleiicine 52.50
L-leucine 52.50
L-lysine 73.10
L-methionine 14.90
L-phenylalanine 33.00
L-threonine 47.60
L-tryptophan 10.20
L-tyrosine 36.20
L-valine 46.90
Table 2.1.4.2. Glasgow modification of M.E.M. Vitamins
- Formulation.-
mg/litre
D-calcium pantothenate 2.0
Choline chloride 2.0
folic acid 2.0
i-inositol 4.0
nicotinamide 2.0
pyridoxal HCl 2.0
riboflavin 0.20
thiamine HCl 2.0
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Table 2.1.4.3. Earle's Balance Salt Solution (BSS) lOx 
concentrated.
NaCl
KCl
MgSO^.TH^O 
NaH2P04- 
CaCl^.6H2O 
Phenol Red 1% 
Distilled water to
To make 10 litres 
680g 
40g 
20g 
14g 
39.3g 
150ml 
10 litres
Add chloroform to a final concentration of 0,1%
i.e. 10 ml chloroform to 10 litres BSSxlO.
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Table 2.1.4.4. Eagle's stock. lOx concentrated (ESxlO).
M.E.M. amino acids x 50 
M.E.M. vitamins x 100 
L. Glutamine 
Glucose
Distilled water to
1 litre 
200ml. 
200ml. 
2.925g 
45g.
1 litre
Adjust pH to 7.1 using 5NNaOH approx. 10ml.
Sterilise by millipore filtration using a G.S. membrane (0.22p)
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Table 2.1.4.5.
IF (Glasgow Modification)
Components
D-glucose
Magnesium sulfate
Potassium chloride
Sodium chloride
Sodium dihydrogen phosphate,
Calcium chloride,
L-Arginine hydrochloride 
L-Cystine, disodium 
L-glutamine
L-Histidine hydrochloride, H^O
L-Isoleucine
L-Leucine
L-Lysine hydrochloride
L-methionine
L- phenylalanine
L-threonine
L-tryptophan
L-tyrosine
L-valine
D-Ca-pantothenate
Choline Chloride
Folic acid
I-Inositol
Nicotinamide
Pyridoxal hydrochloride
Riboflavin
Thiamin hydrochloride 
Phenol Red, sodium
mg/litre
4500.00 
200.00
400.00
6400.00
140.00 
264.90 
126.40
28.42
584.60
21.00
52.46
52.46 
73.06 
14. 92 
33.02 
47.64
8.16
36.22
46.86
2.00
2.00
2.00
4.00
2.00 
2.00 
0.20 
2.00
17.00
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III. Sodium bicarbonate.
5.6% (w/v) NaHCo^ $ 0.0015% (w/v) phenol red. Sterilized 
by millipore filtration using 0 .22micron membrane.
IV. Penicillin and Streptomycin.■
Penicillin 10^ units/litre
Streptomycin lOg/litre
Sterilized by millipore filtration through 0.22 micron 
membrane.
V. Trypsin (in citrate) 0.25%.
9 /1
Trypsin 2.50
Tri-sodium citrate 2.96
Sodium chloride 6.15
Phenol red _0.015
Sterilized by memibrane filtration through 0.22 micron 
membrane.
VI. Versene solution.
9/1
Sodium chloride 8
Potassium chloride 0.2
Di-sodium hydrogen 
phosphate 1.15
Potassium di-hydrogen 
phosphate 0.2
Versene (ethylene diamine 
tetra acetic acid) 0.2
Phenol red 0.015
Sterilized by 15 lb/in^ for 15min.
VII. Trypsin/versene.
1 volume of trypsin (in citrate) 0.25%
4 volumes of versene solution
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VIII. BSS+Bicarbonate.
BSS 450ml
NaHCOg 20ml
IX. Formal saline.
per litre
NaCl 5g
Na2S0^ 15g
Formaldehyde (40%) lOOmls
X. Giemsa Stain.
per litre
Giemsa stain 7. 6g
Glycerbl 500ml
Methanol .500ml
XI. Phosphate buffered saline, PBS.
Sodium chloride 
Potassium chloride 
Di-sodium hydrogen phosphate
gA 
10 
0. 25 
1.44
Potassium di-hydrogen phosphate 0,25 
PH to 7.2.
XII Eagles*s stock, lOX concentrated.
MEM amino acids xlOO 20ml
MEM vitamins : 'xlOO 20ml
glucose 4g
glutamine 0.6375g
PH to 7.1 with 5M NaOH, final volume 220ml. Sterile
filtration through 0.22 micron millipore membrane.
1 'ESIO was prepared with minus methionine or the normal
concentration of methionine, MEM amino acids XlOO, as well
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2.1.4.2. Solutions for the isolation of ribosomal RNA.
I• High salt buffer (HSB).
Sodium chloride 0.5M
Magnesium chloride 0.05M
Tris-base - 0.0IM
PH 7.4
II. LETS buffer.
Lithium chloride O.IM
EDTA 0.0IM
Tris-base 0.0IM
Sodium lauryl sulphate 0.2% (w/v)
PH 7.4
III. Mixed detergent solution.
2 volumes of Tween 80 solution ; 10% (v/v).
1 volume of sodium deoxycholate solution; 10% (w/v).
IV. Reticulocyte standard buffer (RSB)
Sodium chloride 0.0IM
Magnesium chloride 0.003M
Tris-base , O.OIM
PH 7.4
V . Sucrose solution.
15% and 30% sucrose in LETS buffer (w/v).
2.1.4.3. Solutions for polyacrylamide gel electrophoresis
A . RNA
I, Acrylamide stock solution (xlO).
Acrylamide 27%( w/v)
Ethylene diacrylate 2.5 (v/v)
II. Electrophoresis buffer stock X.T(B
Sodium di-hydrogen phosphate 0.3M
EDTA lOirîl
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III
ÎV
V.
Tris-base 0.35M
PH 7.7 to 7.8 with 
Electrophoresis buffer (prepared fresh).XI.
H3PO4.
Electrophoresis buffer xlO 200ml
Sodium Lauryl sulphate 4g
Distilled water added up to 2 litres. 
Sucrose Solution.
Sucrose 20%
SDS 0.4%
in Electrophoresis buffer xl.
2.7% acrylamide gels.
Acrylamide stock solution xlO 
TEMED
Ammonium persulphate 10% (w/v) 
Electrophoresis buffer stock xlO 
added distilled water up to 10ml..
per 10ml 
1ml
0 .01ml
0 . 1ml
1ml
B. Protein.
I. Electrode Buffer.
Tris-base 6.0g 0.025M
Gly cine 28.7g 0.192M
Sodium Lauryl sulphate (10% w/v)20ml 0.1%
up to 2 litres with distilled warer, PH 8.3.
IÎ. Main gel solution.
SDS 0.1% (w/v); TEMED 0.025% (v/v); Ammonium 
persulphate 0.0375% (w/v); Tris base 0.375M, PH 8.8 
with acrylamide 3% and bis-acrylamide 0.09% (w/v).
IV. Staining solution.
Coomassie brilliant blue 0.25% in 45% (w/v) Methanol 
and 5% (v/v) glacial acetic acid.
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V. Destaining solution.
45% (v/v) methanol, 5% (v/v) glacial acetic acid.
VI. Isoelectric focusing gel solution.
Urea 9.2M; Nonidet P-40 2% (w/v), Ampholines 2% (w/v)
(pH 3.5 to 10 1.2%; pH 3.5 to.5 0.2; pH 5 to 7 0.2%;
pH 7 to 9 0.2%; pH 9 to 11 0.2%;)with acrylamide 3.77%
(w/v) and bis-acrylamide 0.215% (w/v) Ammonium
persulfate 0.01% (w/v); TEMED 0.07% (v/v);
€
VIII. Electrode buffer for isolectric focusing, 
a.Cathode (+)
NaOH 0.02M (pH about 12.5).
o.Anode (-)
HgPO^ O.OIM (pH about 3).
2.1.4.4. Solutions for liguid Scintillation counting.
I Toluene - PPG
PPO 0.5% (w/v), in toluene.
II. Toluene-methoxyethanol PPO.
PPO 0.5% (w/v), in toluene-methoxyethanol (40;60).
Ill Stacking gel solution.
SDS 0.1%(w/v) ; TEMED 0.025%(v/v); Ammonium persulfate 
0.037j,^ (w/v") ; Tris base 0.125, pH 5,8 with acrylamide 
3M and bis-acrylamide O.C9%(w/v).
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2.2. Methods.
2.2.1.' Cell culture techniques.
2.2.1.1. Propagation of cells.
Hela cells (Gey et al., 1952) were used in this study. 
Cells were cultured as monolayers in Petri dishes or in Roux 
bottles or in rotating 80oz Winchester bottles (burlers) 
according to- the technique of House and Wildy (1965), They 
were grown in an atmosphere of 5% air on modified
Eagle's Minimal Essential Medium to which 10% (v/v) calf
6serum had been added. Generally cells were seeded at 20 x 10 
per 80oz glass bottle or 4 x 10^ per Roux bottle or 2 x 10^ 
per petri dish and harvested after 2-3 days growth.
Cell lines were maintained by sub-culturing from 
confluent monolayers. The medium was replaced by about 20ml 
of trypsin-versene solution (1:4, w/v) and the 80oz glass 
bottle was rotated for one minute whereupon the solution was 
replaced by a further 20ml trypsin-versene and the procedure 
was repeated. Most of the final trypsin-versene solution was 
poured off from the bottle leaving 2-3ml and the bottle was 
allowed to rotate at 37° for 5 min by which time the cells had 
become opaque . 20ml of fresh warmed medium was added to the 
bottle with shaking. Detached cells were thoroughly 
resuspended before an aliquot was taken for estimation of the 
total cell number using a haemocytometer.
2.2.1.2. Contamination Checks.
All sterile media and passaged cells,were checked 
regularly for bacterial, fungal or PPLo infection as follows;
(a) Bacterial contamination: aliquots were added to blood
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agar plates and brain-heart infusion broth at 37°C. Results 
were considered to be negative if no growth was seen after 
7 days.
(b) Fungal contamination: aliquots were added to Sabourand's
medium at 32°C, No growth after 7 days was assumed to 
indicate the absence of fungal contamination.
(c) PPLo infection: agar plates were seeded with passaged
cells by piercing the agar surface with a charged pasteur 
pippete. The plates were grown in an atmosphere of 5% CO2 
in N2 at 37°C. Infected cells resulted in the occurence of 
the characteristic "fried egg" appearance of PPLo colonies
on examination of the plates under the microscope.Contaminated 
cultures were discarded.
2.2.1.3. Propagation of Virus.
Monolayer cultures of BHK/21 CL3) cells grown to 
confluency were infected with less than 0.01 pfu per cell 
of virus in 20ml medium. Virus was allowed to adsorb for 
Ihr, then the inoculum was removed and replaced with 100ml 
of medium. The cultures were rolled at 37°C for 36hrs, then 
harvested by shaking the bottle to dislodge cells into the 
medium, transferred to centrifuge bottles and spun at 600g 
for lOmin, to pellet the cells. The supernatant was then 
spun at 150 00g for 2hrs to pellet the virus. The pelleted 
supernatant virus was resuspended in culture medium (1ml for 
every burler used) and aliquots were stored at -70°C.
Cell associated virus was prepared by resuspending and 
sonicating the cell pellets. This gives a low titre and was 
used only for production of virus stocks.
Plaque assays carried out on Supernatant virus from
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monolayer cultures of C13 cells and normally gave titres of 
10^ - lO^l pfu/ml.
2.2.1.4. Plague assay for PrV.
Confluent monolayers of C13 cells in 50mm Petri dishes 
were infected with serial dilutions of PrV in 0.2ml medium. 
After Ihr adsorption at 37°C, the medium was poured off, and 
4ml of fresh medium was added and incubation continued. After 
1 hr, 50pg/ml of heparin was added to the medium to prevent 
horizontal transmission of the virus. At 28hrs after infection 
incubation was stopped, and the cell sheet was washed with .
PBS and fixed in 3ml formal-saline per dish, for 30min at 
room temperature. The cell sheets were then stained with 
0.5ml Giemsa stain for Ihr, washed off thereafter very gently 
with H^O and plaques were counted under a low power microscope.
2.2.1.5. Staining of cells for measurement of nucleoli.
Hela cells grown in 50-mm petri dishes containing
microscope slides, incubated at 37°C, were either mock-infected 
or infected with pseudorabies virus. At hourly intervals 
after infection, petri dishes were removed from the incubator, 
the medium was discarded, and cell sheets were washed twice 
with BSS and once with absolute alcohol. Cells on slides 
were fixed in formal saline for Ihr to overnight, stained 
in a Giemsa solution for 1 min washed gently with tap water 
to remove residual stain, dried, covered with coverslips and 
photographed under a high powered Leitz light microscope.
The perimeters of nucleoli were outlined on tracing 
paper with the use of a Nikon comparator. The outlines were 
cut and weighted in a microbalance.
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2.2.2. Radioactive labelling.
2.2.2.1. Proteins.
Hela cells grown to confluence in 80oz roller bottles
in 180 ml of medium for 3 days, were mock-infected or infected
with PrV. Cells were then labelled in 20 ml of medium with
35an appropiate amount of S-methionine in one of the following 
ways :
35(a) Cells were labelled with S-methionine for a period of
5 hrs in medium containing the normal methionine
concentration.
. 3 5(b) Cells were labelled with S-methionine for a period of
2.hrs in medium containing no methionine.
35(c) Cells were labelled with S-methionine for a period of
1 hr in medium containing no methionine following treatment 
of cells, immediately after infection, with an appropiate 
amount of cycloheximide.
For labelling cells before infection they were grown
in 80oz roller bottles for 2 days and labelled with 
35j..,S-methionine for approximately 12 hrs. At the end of this 
period cells were either mock-infected or infected and the 
label was chased with 400-fold cold methionine for a period 
of 6 hrs.
2.2.2.2. RNA.
2.2.2.2.1. Pulse labelled.
Hela cells grown in either 80oz roller bottles or in
Roux bottles, mock-infected and infected were labelled with
3an appropiate amount of H-uridine in 20 ml medium for periods 
of 1 hr or 15 min.
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2.2.2.2.2. "Glucosamine-uridine" pulse-chase,
"Glucosamine-uridine pulse-chase experiments essentialy
followed the method of Levis and Penman (1977). Hela cells
grown in Roux bottles in 50 ml of medium for 3 days, were
mock-infected or infected. Cells were then brought to 20 ml
of medium and D-glucosamine, neutralised to pH 7.4, was
added to a final concentration of 20 mM. This concentration
of glucosamine is sufficient to reduce considerably the size
of the intracellular UTP. pools by "trapping" uridine in the
form of UDP- N - acetylhexosamines (Scholtissek, 1971).
Incubation at 37°C was continued for 60 min and then the
3 . .culture was labelled with an appropriate.quantity-of H-uridine 
for 15 min.
To initiate the chase, the medium was discarded and 
fresh medium was added, containing 5mM uridine, 5mM cytidine 
and 5mM glucosamine. The label was chased for 30, 60 or 
120 min.
2.2.2.3. ' DNA.
Hela cells grown in Roux bottles for 2 days were
3labelled with an appropriate amount of H-thymidine. At 
approximately 12 hrs the medium was changed and cells were 
either mock-infected or infected and the label was chased 
with excess cold thymidine.
2.2.3. Cell harvesting.
Growth medium was decanted and the cell sheet rinsed 
with ice-cold BSS. The cells were removed from the glass 
into 30 ml of freshly added BSS by means of a rubber scraper, 
transferred to a 50 ml centrifuge tube, and pelleted by
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centrifugation at 1000 rpm for 5 min (+4°C) in an MSE Major 
centrifuge.
2.2,4. Cell fractionation. .
2.4.1. Nuclei and cytoplasm.
Nuclei were isolated according to the method of Penman 
(1966). All steps were carried out at +4°C. The cell pellet, 
after removal from the glass surface and washing with BSS as 
described above, was suspended in RSB (0.01 M NaCl; 0.0015 M 
MgCl^; 0.01 M Tris/HCl pH 7.4). 4.0ml of RSB were added per
10^ cells, and the cells allowed to swell by standing in ice 
for 10 min. Disruption was completed by homogenizing with 25 
strokes of a stainless steel Dounce homogeniser, and crude 
nuclei were pelleted by centrifugation (2K, 10 min). The 
crude nuclear pellet was resuspended in 2 ml RSB and pelleted 
by centrifugation again (2K, 5 min) to remove "trapped" .i 
residual cytoplasm. The supernatants containing the 
cytoplasm were combined and were either used to prepare 
cytoplasmic RNA or were centrifuged at lO.OOOg for 15 min, 
to p^LLeA mitochondria, to be used in studies for the 
uptake of cytoplasmic proteins by isolated nuclei in vitro.
The nuclear pellet was suspended in 4.0 ml RSB to which 
was added 0.6 ml of a solution containing 6.7% tween 80 and 
3.3% Na deoxycholate. The suspension was mixed briefly on a 
vortex mixer and the nuclei pelleted by centrifugation at 
2.000 rpm for 5 min. This treatment removes residual 
cytoplasmic contamination and unruptured cells (Penman, 1965). 
The purified nuclear pellet was either dissolved in SDS-sample 
buffer to prepare it for electrophoresis or used for nucleolar 
purification if required.
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2.2.4.2. Nucleoli.
Nucleoli were prepared in one of two ways;
2.2.4.2.1. DNase.
The purified nuclear pellet was used to prepare 
nucleoli according to the method of Penman (1966). Residual 
detergent from the nuclear pellet was removed by rinsing its 
surface with 1,0 ml of RSB. This facilitated the subsequent 
action of DNase (Pederson and Kumar, 1971). The gelatinous 
pellet was suspended in 2.0 ml of HSB (0.5 M NaCl; 0.05M MgCl2 ! 
0.01 M Tris/HCl pH 7.4), 100 pg of DNase added, and the 
mixture incubated at 37°C with vigorous pipetting, using a 
broken off wide bore pasteur pipette, until all DNA clumps 
were dispersed and the viscosity of the solution was reduced 
considerably (approximately 1 min incubation was sufficient).
The nucleoli were collected by centrifugation through 
a cushion of 0.88M sucrose at 2900 for 30 min. The nucleolar 
pellet was then extracted to prepare nucleolar RNA,
2.2.4.2.2, Sonication.
Essentialy the method of Muramatsu et al., (1974) was
used. The detergent purified nuclei were suspended in 5 ml
of 0.25 M sucrose and 10 mN NgC12 and pelleted, resuspended
in 5ml of 0.34M sucrose and 0.5mN MgCl2 and sonicated four
times at 20 sec each time with a minute interval between each
sonication, to destroy all nuclei, which was confirmed by
examining a drop of the sonicate under a light microscope
after staining with Azure C. (Muramatsu et al., 1963). The
sonicate was immediatly underlaid with an equal volume of
0.88 M sucrose and centrifuged at 2.900 rpm for 30 min in an 
Moi:. iUjor centrifuge to sedci.ient the nucleoli
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Figure 2.2.4,1, Nucleoli isolated by sonication from
mock-infected llela cells.
Hela cells grown in 80oz roller bottles were 
mock-infected or infected with pseudorabies virus at 50 p.f.u. 
per cell. At 5 hrs postinfection cells were harvested and 
nucleoli were isolated by sonication as described in Materials 
and Methods. Samples from the pelleted nucleoli were applied 
on microscope slides, stained with Azure G, covered with 
coverslips and photographed under a Leitz light microscope.
a. mock-infected b, PrV-infected.
Magnification x240.
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Purified nucleoli of mock-infected and infected Hela cells 
are shown in figure 2.2.4.1.
The nucleolar pellet was either dissolved in SDS-sample 
buffer to prepare for electrophoresis or used for preparation 
of nucleolar chromatin if required. (Photographs of nucleoli 
were taken in the light microscope),
2.2.4.3. Nucleolar chromatin.
For preparation of nucleolar chromatin, the method 
described by Daskal et al., (1978) was essentially used.
This employs two washings of the nucleolar pellet in 0,075 M 
NaCl; 0.025 M EDTA (tetrasodium salt); ImM PMSF, adjusted to 
pH 8.0 with 1 N NaOH, followed by 3 washings in Tris-buffer 
(0.01 M Tris, pH 8.0; 1 mM PMSF). The pellet from the third 
washing represented isolated chromatin.
2.2.5. RNA isolation.
2.2.5.1. Extraction of whole cell RTCA,
Hashed Hela cells were lysed by addition of an 
appreciate volume of lysing LETS, and diluted with an equal 
volume of phenol saturated with water. The mixture was 
stirred in a Vortex mixer for 1 min,then incubated in a 50°C 
to 55°C water both for 4 min with occasional shaking and 
centrifuged at 3000 rpm in a»'MSE Major Centrifuge for 30 min ■ 
at 20°C. The aqueous layer was removed and the organic layer 
re-extracted with an equal volume of LETS. The combined 
final aqueous phase was diluted with 3 volumes of ethanol and 
stored at-20°C overnight. The ensuing precipitate of RkiA was 
collected by centrifuging at 3000 rpm for 30 min at 4°C. The 
pellet was later prepared for electrophoresis in acrylamide
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gels.
2.2.5.2. Extraction of cytoplasmic RNA.
'Cytoplasmic extracts prepared as described previously 
were treated with an equal volume of water-saturated phenol, 
shaken on a Vortex mixer for 20 sec then centrifuged at room 
temperature (3000 rpm, 20 min). The supernatant fraction 
was carefully removed by aspiration, replaced by an equal 
volume of LETS buffer and the procedure was repeated. The 
combined aqueous fractions were added to 3 volumes of ethanol 
and stored at -20°C overnight and the RNA collected by 
centrifugation (3000 rpm, 30 min). The pellet was resuspended 
in 1.0 ml LETS buffer, layered over 36.0 ml of a linear 15% 
to 30% sucrose density gradient in LETS buffer, centrifuged 
in the Beclonan SH27 rotor (22000 rpm, 17 hrs , 20°C), then 
harvested by placing a needle do;vn the side of the tube to 
the bottom and pumping through a Gilford 2000 recording 
spectrophotometer. The absorbance was monitored at 260 nm 
and the gradient collected into appropiate fractions. In some 
cases fractions were submitted to a further 2 cycles of 
ethanol precipitation, centrifugation and resuspension as 
above in order to eliminate traces of phenol, and SDS.
2 . 2 . 5. 3 . Extraction of nucleolar R1\A.
Nucleoli prepared as described previously were dissolved 
in LETS buffer and diluted with an equal volume of water- 
saturated phenol. The mixture was agitatejin a Vortex mixer 
for 30 sec then centrifuged at room temperature (3000 rpm,
30 min). The aqueous phase was carefully removed with a 
pasteur pipette, added to 3 volumes of ethanol, stored at
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■20°C overnight and the RNA collected by centrifugation. The 
pellet was resuspended in 1.0 ml LETS buffer and centrifuged 
in 15% to 30% sucrose density gradients as described above 
for cytoplasmic RNA. In some cases nucleolar RNA was prepared 
for electrophoresis in acrylamide gels.
2.2.5.4. Precautions against ribonuclease.
To eliminate possible contaminating ribonuclease 
activity all glassware was baked in an oven at 200-^ C for a
— 2minimum of three hours. Solutions were autoclaved at iSlb.in 
for. 25 min or , if they contained-sucrose, at. 51b. in’”" for 40mto 
to 50mih. vrhônèver'possible,relevaht ' items of .experimental, 
apparatus were autoclaved as above.
2.2.6. RNA fractionation.
2.2.6.1. Non-denaturing sucrose gradients.
Ah.appropriate amount of RNA was dissolved in LETS 
buffer and layered over a linear 15% to 30% sucrose gradient 
in LETS buffer. The gradient was fractionated by using a 
peristaltic pump to withdraw the tube contents from the 
bottom and an aliquot of each fraction was assayed for acid 
soluble radioactivity, as described below.
2.2.6.2. Polyacrylamide gel electrophoresis.
Electrophoresis was carried out on 2.7% acrylamide gels
prepared as described by Knowler and Smellie (1971). Gels 
contained 2.7% (w/v) acrylamide, 0.25% (v/v) ethylene 
diacrylate, 1% (v/v) TEMED, prepared in electrophoresis 
buffer (36mM Tris, 30mM NaH^PC^, limM EDTA pH 7.7-7.8) as 
described by Loaning (1969).
Polymerization was catalyzed by the addition of
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ammonium persulphate to 0.1% (w/v). All gels were 
pre-electrophoresed at 2.5mA/gel for 15-30 minutes before 
RNA samples (80-100;g), dissolved in electrophoresis buffer 
containing 20% (w/v) sucrose and 0.2% (w/v) SDS, were^applied 
on top. Electrophoresis was 2 to 5 hours at 5mA/gel. The 
gels were scanned at 260 nm in the linear transport  ^
attachment for the Gilford 240 recording spectrophotometer.
For determination of radioactivity the gels were frozen in 
powdered solid CO^ and cut transversely into 1mm slices
using a Mickle gel slicer. Slices were digested individually
in vials with 0.5ml of aqueous 2M NH^OH at 60° overnight, 
taken up in 0.3ml water, left for 60 minutes and counted in 
10 ml of methoxyethanol-toluene PPO based scintilation fluid, 
after shaking and allowing them to stand for a few minutes.
2.2.7. In vitro protein uptake by nuclei. '
Crude unlabelled nuclei of mock-infected or infected
35Hela cells, were incubated in S-methionine labelled 
cytoplasmic extracts in RSB derived from mock-infected or 
infected Hela cells, for periods of 30 to 60 minutes. Crude 
nuclei were washed afterwards with detergents to remove 
cytoplasmic contaminants, pelleted and were either extracted 
with 0.35 M NaCl and dissolved in SDS buffer for electrophoresis 
in polyacrylamide gels or were used to prepare nucleoli by 
sonication as described previously. Nucleoli were also 
dissolved in SDS buffer and prepared for electrophoresis.
2.2.8. Analysis of proteins.
2.2.8.1. Protein estimation.
Protein was estimated using the methods of either
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etK&,
Lowry (1951) or Bradford (1976). Bovine serum albumin was 
used as a protein standard.
2.2.8.2. SDS-polyacrylamide pel electrophoresis.
Electrophoresis was carried out using the discontinous
system essentialy as described by Laemli (1970).
For routine analysis of nuclear or sub-nuclear fractions 
the technique of thin-slab SDS polyacrylamide gel electrophoresis 
was employed as described by Lestourgeon (1977). The gels 
were prepared by layering 2o mm of 3.0% acrylamide stacker 
gel solution (0.125 M Tris, 0.1% SDS, pH 6.8) over 80 mm to 
100 mm of either 15%, 12.5% or 9% acrylamide main gel 
solution (0.375 M Tris, 0.1% SDS, pH 8.8). Acrylamide was 
polymerized by the addition of ammonium persu^te (0.0375%) 
and TEMED (0.025%).
Proteins were denatured prior to electrophoresis, in 
SDS sample buffer (0.1% SDS, 1% mercaptoethanol, 0.25 M 
sucrose, 1,9 mH NaH^PO^, 8.1 mM Na2HP0^, pH 7.4), by heating 
in a boiling water bath. Multiple samples with an appropriate 
amount of protein, in a 20 pi to 100 p.l volume, were applied 
to the gel and Bromo phenol Blue added as a tracking dye.
Electrophoresis was carried out at 20 mA until the 
tracking dye was approximately 1 cm from the end of the gel.
The thin slab gels were removed carefully and either stained 
with Coomasie blue and autoradiographed or immersed in a PPG 
based solution to prepare for flurography,. Gels were dried 
prior to exposure to X-ray films on filter paper supports.
2.2.8.3. Two-dimensional gel electrophoresis.
Two-dimensional gel electrophoresis was carricèd out
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according to the 0'Farreilmethod. Labelled polypeptides from 
nucleolar and nucleolar chromatin fractions were analysed by 
isoelectric focusing - lEF (O'Farrell, 1975) or ncÿ-equilibrium 
pH gradient electrophoresis - NEPHGE (O'Farrell, 1977) 
followed by SDS gel electrophoresis.
Protein samples were prepared either by pelleting 
nucleic acids (150.000g, 18 hrs) after.dissociation in the 
presence of 0.4 M guanidine hydrochloride and 5 M urea or 
after treatment with micrJtocal nuclease, in the presence of 
PMSF. Samples were thereafter treated in lysis buffer (9,5 M 
urea, 2% NP-40, 5% B-mercaptoethanol, 2% Ampholines) and 
appropriate amounts were applied to isoelectric focusing 
gels and run as recomended by O'Farrell.
Following isoelectric focusing, gels were equilibrated 
in SDS sample buffer and loaded on thin layer SDS-polacrylamide 
gels prepared as described above.
2.2.8.4. Estimation of molecularweiqhts.
Gels were calibrated by co-electrophoresis of albumin 
(58.000), trypsin inhibitor (21.000) and RMA polymerase 
(39.000, 155.000, 155,000), After electrophoresis gels were 
stained. The molecular weight
of the standards was plotted against their migration distances 
on semi-logarithmic paper.
2,2.9. Determination of radioactivity.
2.2.9.1. Acid-insoluble radioactivity.
Radioactivity in acid-insoluble RNA molecules was 
determined by precipitation with ice-cold trichloroacetic 
acid 5% or 10% (w/v) and the ensuing precipitate collected by
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vacuum filtration dvi to millipore filters (0.45 pm pore size) 
or onto Whatman GF/C glass fibre discs. The discs were . 
washed with 5% TCA and ethanol placed individually in 
scintillation vials and oven-dried (60°,2 hrs). Radioactivity 
was determined following addition of a 0.5% solution of PPG 
in toluene, by liquid scinti^ation spectrometry.
In other cases samples of 10 pi were spotted onto 
Whatman I filter paper discs, dried briefly, immersed in 
cold 10% TCA (10 ml per filter) stirred at a low speed for 
15 min washed afterwards with absolute alcohol then in 
diethyl-ether, dried under a heat lamp, placed in scintillation 
vials and radioactivity was determined in toluene-PPO as above.
Where radioactively labelled nucleoside triphosphates 
were present, precipitation of acid insoluble material in 
cold TCA was carried out in the presence of 0.1 M sodium 
pyrophosphate.
2,2.9.2. Assay of radioactivity present in polyacrylamide 
gel slices.
Gel slices were placed in scintillation vials to which 
was added 0.5 ml of aqueous 2M NH^OH, and were heated at 60° 
overnight. After evaporation to dryness, gel residues were 
taken up in 03 ml water and left for 60, min. Radioactivity 
was counted in 10 ml of a solution containing 0.5% PPG in 
methoxyethanol-toluene (60:40).
2.2.10. Detection of labelled polypeptides separated on 
gels.
2.2.10.1. Autoradiography.
After electrophoresis gels were stained in Coomasie blue
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and dried under vacuum ov^ to Whatman 3 MM chromatography paper. 
The dried gel was placed in contact with kodirex KD 54T X-ray 
film and exposed at room temperature for the appropriate time. 
The film was developed in kodak DX-80 developer and fixed with 
kodak FX-40 X-ray liquid fixer.
2.2.10,2. Flurography.
The method of Bonner and Laskey (1974) was used to 
detect radioactive polypeptides by fluorography. After 
elecrophoresis, gels were soaked in three changes of DMSG 
for a total period of 2.5 hrs, impregnated with PPG by 
immersion in a solution of 22.2% (w/v) PPG in DMSG for 1 hr 
and then washed with water before drying under a vacuum. The 
dried gel was placed in contact with X-Gmat H X-ray film and 
exposed at-70°C for the appropriate time. Films were 
developed as described above.
2.2.11. . RI'niA polymerase assays.
2.2.11.1. Standard procedure.
Nuclei isolated from Hela cells mock-infected or
infected were assayed for RNA polymerase activity in a
200 pi incubation mixtures at 25°C containing 50 mM Hepes
pH 7.6, 25% glycerol,5mM Mg-acetate,5mM dithiothreitol, 150mM
KCl and 0.4 mM of each GTP, ATP, GTP plus 0,05 mM UTP. 10 
3pci/ml of H-UTP was added to each assay. Incubation was 
carriedAfor up to 30 mins, lOpl aliquots were spotted on 
Whatman I papers,dried, extacted with 10% TCA-1% pyrophosphate 
and their radioactivity was determined. Gccasionaly 200jig/ml 
of amanitin was added to the incubation mixture.
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2.2.11.2. Incubation with sarkosyl.
In some cases nuclei were incubated in the presence of 
0.8% of sarcosyl in 80 pi incubation mixture constituted as 
above. Reaction was stopped by the addition of 1% SDS,
1 mM EDTA and TCA precipitable material was collected on GF/C 
Oj» millipore filters.
2.2.11.3. Incubation in cytoplasmic extracts.
RNA polymerase was assayed after coincubation of the 
nuclei with cytoplasmic extracts, prepared after sonication 
in salt solution for 5 min followed by pelleting of the u ' 
nuclear debris for 15 min at 17K. The 200-pl incubation 
mixture was assayed at 25^C, and 10 pi aliquots were spotted 
on Wiatman I papers. Occasionally sarkosyl was also used in 
polymerase assays as above. The incubation in cytoplasmic 
extracts for 15' was followed by treatment with sarkosyl for 
10'. Reaction was stopped with addition of 1% SDS and EDTA.
2,2.12. DNA gradients.
A suspension in SSC (0.15 M NaCl, 0.015M sodium citrate) 
of mock-infected or infected Hela cells was carefully pipetted 
into 2 mis of a solution containing 0.3N NaOH, 0.00 M EDTA 
and 0.5% SDS layered onto 15% to 30% sucrose gradients in 
0.5M NaCl, 0.25N NaOH, O.OOIM EDTA, 0.01% SDS. The gradients 
kept at room temperature for at least 8 hours and centrifuged 
at 26K for 5 to 5 hours at 25°C in a Bechman SW27 rotor. 
Gradients were harvested with a peristaltic pump and were 
divided into 1 ml fractions. Radioactivity in each fraction 
was determined after TCA precipitation and collection of the 
precipitate onto GF/C filters by means of vacuum filtration.
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CHAPTER '3. Changes in nucleolar morphology following
infection of Hela cells with pseudorabies virus,
3.1. Introduction.
The nucleolus, which is the site of ribosomal RNA 
synthesis, is an organelle which is highly sensitive to 
external stimuli, and its size and structure can be altered 
by a variety of agents and experimental conditions which are 
known to exert changes on cellular RNA metabolism.Thus an increase 
in nucleolar size, which coincides with an-increase in nucleic 
acid synthesis,is observed in livers Of rats treated with 
thioacetamide (Bernhard and Granboulan, 1968).
Again when actinomycin D is administered to cultured 
cells, a decrease in nucleolar size is observed among other 
characteristic changes (Rounds et al., 1960; Reynolds, 1969; 
Schoefl, 1964). Actinomycin, as well as a number of other 
agents known to produce the same decrease in nucleolar 
size, inhibit primarily ribosomal RNA synthesis.
Viruses are also known to induce changes in nucleolar 
size and structure. Their effect is variable depending 
mainly on the mode of action of the particular virus 
involved (Bernhard and Granboulan, 1968). In kB tumour 
cells infected with herpes simplex virus, a decrease in 
nucleolar size was observed,accompanied by other structural 
changes which resembled the changes caused by actinomycin 
(Sirtori and Bossisio-Bestetti, 1967).
Unfortunately, no quantitative estimation of the
I
nucleolar size was made by these authors.
It has been reported that the number of nucleoli per 
cell varies in any particular cell type. What appears to be
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the constant feature for a cell type is the total nucleolar 
volume rather than the number of nucleoli (Jordan, 1972). 
Furthermore, there are indications that the total surface 
area rather than the combined volume may be the constant 
feature.(Barr and Esper, 1963).
From such studies, it is clear that the size of nucleoli 
reflects the metabolic state of the cell and particularly 
ribosomal RNA metabolism.
3,2. Changes in nucleolar cross-sectional area.
Nucleolar cross-sectional area was measured, rather 
than of volume but it is believed that by analogy with 
similar measurements for nuclei (Harris, 1967) this gives 
a reasonable approximation.
Hela cells grown in 50mm petri dishes on microscope 
slides were mock-infected or infected with PrV and at hourly 
intervals up to 6 hours postinfection, slides were removed, 
fixed and stained with Giemsa solution as described in 
Materials and Methods, Cells on slides were examined by 
light microscopy and photographed (Fig, 3.2.1) The cross- 
sectional area of individual nucleoli from cells in fields 
chosen at random was estimated as described in Materials and 
Methods.
Histograms giving the number of nucleoli at each unit 
size are shown in Fig 3.2.2, and reveal a greater spread of 
values in mock-infected than in infected cells. There is a 
gradual accumulation of the bulk of nucleoli at the lower 
size units at late times after infection as is seen by the 
absence of nucleoli greater than size unit four from 4 hours
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Figure 3.2.1. Hela cells mock-infected or infected with L-
PrV.
Monolayers of Hela cells grown on microscope slides 
contained in 50-mm Petri dishes were mock-infected or infected 
with pseudorabies virus at a multiplicity of 50 p.f.u./cell.
At hourly intervals after infection, slides were removed, 
washed in BSS and absolute alcohol, fixed in formal saline 
and stained with Giemsa. . Slides were further washed, dried, 
covered with coverslips and photographed under a Leitz light 
microscope.
a; mock-infected (5 hrs).
b; PrV-infected (5 hrs). Magnification X 240.
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Figure 3,2.2. Distribution of nucleoli of given.cross-sectic
area during infection.
The perimeters of nucleoli from photographic negatives 
of mock-infected or infected Hela cells prepared as described 
in the legend of Figure 3.2.1, were outlined on tracing paper 
with a Nikon comparator. The outlines were cut and weighted 
in a microbalance. The nucleoli from.a total of about 50 
individual cells were examined for mock-infected and infected 
at hourly intervals up to six hours postinfection.
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Figure 3.2.3. Mean cross-sectional area of individual
nucleoli during infection.
The mean value of the cross-sectional area of nucleoli 
was estimated in Hela cells prepared as in Fig. 3.2.1 and 
analyzed as in Fig. 3.2.2. Mean values were estimated at 
hourly periods after infection.
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post-infection and the 14% to 52% rise in the percentage of 
nucleoli at size unit one, at 6 hours postinfection. Again 
this change is reflected in a decline in the average cross- 
sectional area of individual nucleoli as the infection 
proceeds. This reaches values as low as 45% of the. control. 
(Fig. 3.2,3.),
3.3. Changes in total nucleolar area per cell.
In view of the above, it seemed that a characterisation 
of total area of nucleoli per cell would be of value in 
assesing the changes produced as a result of infection.
The data obtained the same way as before (Fig. 3.3.1), 
show a decline in total nucleolar area per nucleus, giving 
an average of 6.5 size units for the mock-infected compared 
with an average of 1,9 size units for the infected cells at 
6 hours after infection (Table 3.3,1), This decline (as the 
infection proceeds) is more dramatic than that noted for the 
individual nucleolar area (Fig. 3.2.3) and reaches values as 
low as 35% of the control (Fig. 3.3.2).
It is assumed to reflect a concomitant decrease in 
nucleolar RNA metabolism as suggested in the introduction 
and confirmed in chapter 4.
3.4. Changes in the number of nucleoli per cell.
As was mentioned earlier, the number of nucleoli per 
cell varies depending on the metabolic state of the cell. An 
average of 1,7 nucleoli per cell was found for Hela cells 
when cultured in complete medium, whereas on incubation in
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Figure 3.3.1, Total nucleolar cross-sectional area per
cell during infection.
The total nucleolar cross-sectional area per cell was 
estimated in Hela cells prepared as in Fig, 3.2,1. and 
analyzed as in Fig. 3,2.2.
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Figure 3.3.2. Mean total nucleolar cross-sectional area
per cell during infection.
The data of Table 3.3.1 were used to prppare this 
figure.
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Table 3,3.1. Mean values and standard deviations of total
nucleolar cross-sectional area during infection 
The mean values and standard deviations of total 
cross-sectional areas were calculated from Fig. 3.3.1, at 
hourly intervals after infection.
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Table 3.4.1. Number of nucleoli per cell during infectionj
mean values and range. ■ .
The range and average number of nucleoli per cell were 
estimated from photographic negatives of mock-infected or 
infected Hela cells prepared as described in Fig. 3.2,1.
Time after 
infection (h)
0
1
2
3
4
5 '
ilo. of nucleoli per
cell(Mean of 50 celi^l
2.0
1.7
Range
1-5
1-5
1-5
1-45
1-5
1—4
1-5
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Figure 3.4.1 Percentage of cells with one nucleolus during 
infection.
The percentage of cells with one nucleolus was derive 
froiii Table 3,4.1.
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in salt solutions free of amino acids the number of nucleoli 
per cell averaged 3.7 and ranged from 1 to 8, with an 
additional decrease in size (Swift, 1959), thus this suggests 
a relationship between the number of nucleoli per cell and 
the medium in which the cells are incubated.
In the Hela cells used in the experiments described in 
this chapter, an average of 2.6 nucleoli per cell was found 
for normal non-infected cells and the range was from 1 to 5 
nucleoli per cell. Virtually the game average of nucleoli 
per cell was found in the infected cells (Table 3.4.1) at 
early times when it then declined at 5 hours and 6 hours to 
2.0 and 1.7 respectively.
Furthermore, the percentage of cells with one nucleolus 
per cell rose to 50% at 6 hours (Fig. 3.4.1).
3.5. Discussion.
As noted in the introduction , nucleolar size and 
ribosomal RNA metabolism are coupled and any change in one 
of these should affect the other. Thus the decrease observed 
in nucleolar cross-sectional area and particularly in the 
total nucleolar area in Hela cells infected with PrV would 
be expected to reflect an analogous decrease in ribosomal 
RNA metabolism. Whether there is and what is the cause of 
this decrease in ribosomal RNA is dealt with in the next •. . 
sections, though an indication of the cause could be taken 
from the number of nucleoli per cell which declines during 
infection indicating that nucleoli are not fragmented 
following virus attack thus allowing us to assume that the 
pseudorabies virus acts through interference with the DNA 
template. This is fully discussed in the General Discussion.
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CHAPTER 4, Synthesis of ribosomal RNA in Hela cells
following infection with pseudorabies virus.
4.1. Introduction
Total RNA synthesis in herpesvirus-infected Hela cells
3as judged by incorporation of exogenous H-nucleosides declines 
considerably in the course of infection (see Introduction).
Incorporation of radioactivity into the nuclear RNA of 
Hep-2 cells after infection with herpesvirus is rapidly 
reduce#) The same appears to be true for cytoplasmic ribosomal 
RNA (Wagner and Roizman, 1969). Furthermore, several authors 
have observed a substantial decline in ^H-uridine incorporation 
into 45s pre-rRNA. They have not made a quantitative estimate 
of this decline (Wagner and Roizman, 1969; Flanagan, 1964;
Hay et al., 1966).
In order to assess the decline in the rate of RNA 
synthesis after infection, as determined by incorporation 
rates of exogenous precursors, quantitation of the precursor 
pools is required (Harbers et al., 1959; Emerson and Humphreys, 
1971; Houschka, 1973). When incorporation of label into RNA 
is corrected for changes in the specific radioactivity of the 
UTP precursor pool, the variables involved in cellular 
transport and isotOpe dilution in precursor pools are avoided 
(Bucher and Swaffield, 1969; Yu and Fiegelson, 1970; Kalra and 
Wheldrake, 1972; Kaukel et al., 1972; Cortes et al., 1976). 
However estimation of the rate of RNA synthesis could be 
subject to significant errors, if RNA were formed from a 
compartmented nucleotide precursor pool that was not in 
equilibrium with the main cellular nucleotide pool (Goody and
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Ellem, 1975). Evidence for a separate UTP pool, from which 
rRNA is formed has been provided in the case of cells in 
culture (Wiegers et al., 1976).
Therefore the suggestion that the size of the total 'r. 
intracellular UTP pool remains unchanged after infection of 
RK monolayer cells with pseudorabies virus (Rakusanova et al., 
1972) does not exclude possible changes in the UTP pool 
responsible for rRNA synthesis.
34.2. Incorporation of H-ùridine into ribosomal RNA.
It is well established that the nucleolus is the site 
of ribosomal RNA synthesis and any study on rRNA synthesis 
would be more revealing if nucleolar RNA were examined rather 
than nuclear or whole cell RNA,
Thus in this study, nucleoli were isolated from DNase 
treated nuclei of Hela cells grown in 80oz roller bottles, 
mock-infected or .lnfebted with PrV.and ;labelled :for one hour 
with ^H-uridine as described in Materials and Methods. Phenol 
extracted nucleolar RNA was analyzed on 15% to 30% (w/v) linear 
density sucrose gradients and absorbance and radioactivity were 
determined as described in Materials and Methods. Fig. 4.2.1 
shows that the radioactivity incorporated into 45s and 32s 
pre-rRNA falls after infection. However, an estimation of the 
decrease of ^H-uridine incorporation into newly synthesized 45s 
pre-rRNA is hindered by the length of the radioactivity pulse 
employed,which allows processing of 45s to 32s to take place.
4.3. Specific radioactivities in pooled fractions of 45s 
and IBs rRNAs.
As can be seen in the figures presented in the previous
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Figure 4.2.1. Optical density and radioactivity profiles
of nucleolar RNA separated on' sucrose density 
gradients at various times after infection.
Confluent monolayers of Hela cells grown in BOoz roller
bottles were mock-infected or infected with pseudorabies
virus at a multiplicity of 50 p.f.u./cell. At different
times after infection cells were labelled with 5pCi/ml 
3H-uridine for a period of one hour before harvest.
Nucleoli were isolated by the DNase method of Penman 
and collected by centrifugation through a cushion of 0.88M 
sucrose at 2.900 RPM for 30 min in an M.S.E Major centrifuge. 
Phenol-extracted nucleolar RNA, was suspended in 1.0 ml LETS 
buffer, layered over 36 ml of 15% to 30% (w/v) linear sucrose 
density gradients in LETS buffer and centrifuged in the 
Beckman SW 27 rotor (22.000 rpm, 17 hours, 20^C). Gradients 
were harvested by aspiration through a needle placed at the 
bottom of the tube and absorbance was monitored in a Gilford 
2000 recording spectrophotometer. The TCA precipitable 
radioactivity of individual fractions was determined.
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section, the resolution of RNA species is not ideal in a linear 
density sucrose gradient and there is also a considerable 
amount of background due probably to the effect of residual 
phenol. These technical problems could hinder the estimation 
of the specific radioactivity of the RNA species and thus any 
attempts to calculate the decrease of synthesis of ribosomal 
RNA caused by the infection would not be accurate.
For that reason fractions containing specific ribosomal 
RNA species were pooled and re-centrifuged for several cycles 
in order to increase resolution of the particular RNA species 
and to reduce background caused by phenol.
Thus, nucleoli were isolated from DNase treated nuclei
of Hela cells grown in BOoz roller bottles, mock-infected or
3infected with PrV and labelled for 15 min with H-uridine as 
described in Materials and Methods. Phenol-extracted nucleolar 
RNA at 6 hrs postinfection was analyzed on 15% to 30% linear 
density sucrose gradients. 45s pre-rRNA fractions were pooled 
and ethanol precipitated overnight. The ethanol precipitate 
was collected by low-speed centrifugation dissolved in SDS 
buffer and centrifuged again on sucrose gradients. This 
procedure was repeated one more time and the final pooled 45s 
pre-rRNA fractions were analyzed for absorbance and radioactivity 
and specific radioactivities were determined (Fig, 4.3.1),
There is a drop of 60% in specific radioactivity between 
mock-infected and PrV-infected Hela cells at 6 hrs after 
infection (Table 4,3.1).
The same procedure of repeated sucrose gradient
centrifugation was followed for 18s cytoplasmic rRNA of Hela
cells mock-infected and PrV-infected, labelled for 1 hour with 
3H-uridine (Fig. 4.3,2). The drop in specific radioactivity
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Figure 4.3.1. Isolation and purification of 45s pre-rRNA
of mock-infected and 6 hours infected Hela 
cells.
Hela cells mock-infected or infected as in Fig. 4.2.1
3 . .were labelled with 5pCi/ml of H-uridine for a period of 15" 
before harvest at 5 hours post-infection.
Nucleoli and nucleolar RNA were.prepared as described 
in Fig. 4.2.1 Equal amounts of mock-infected and infected 
nucleolar RNA were suspended in LETS buffer and layered onto 
15% to 30% (w/v) linear density sucrose gradients and 
centrifuged in a Beckman SW 27 rotor (22.000 rpm, 17 hrs, 
20°C). Gradients were harvested through a Gilford 2000 
recording spectrophotometer and the 45s rRNA peak was 
collected. The fraction containing 45s rRNA was ethanol 
precipitated overnight, collected, dissolved in LETS buffer 
and centrifuged again. The procedure was repeated once more 
and the optical density and radioactivity of the final fractic 
was determined.
a; 1^^ separation
b; 2^^ separation
c; 3 separation
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Figure 4.3,2, Isolation and purification of 18s rRNA of
mûck-infected and 6 hours infected Hela cells 
Hela cells were mock-infected or infected as in Fig.
4.2.1. and labelled with ^H-uridine for a period of 1 hr 
before harvest at 6 hrs after infection. Cytoplasmic RNA 
was extracted as described in Materials and. Methods. 18s 
rRNA was isolated by sucrose gradient.centrifugation as 
described in Fig. 4,3,1.
o “I* ^
aj 1 separation 
b; 2^^'separation
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Table 4.3.1, Specific radioactivities of 45s and 18s rRNA
of mock-infected and infected Hela cells at 
6 hrs after infection.
Specific radioactivities of 45s and 18s rRNA were 
determined from purified RNA species obtained as described in 
Figures 4.3.1 and 4.3.2 respectively.
SPECIFIC ACTIVITIES at 6 hrs post-infection.
Mock"inf acted 
PrV-infected
18S after 1 hr label. 
8,500 dpm/p.gr 
1.760 dpin/p gr '
45S after 15' label. 
3,200 dpiii/pgr 
1.300 dpm/pgr
INF ,20% of CON INF 40% of CON
95..
in 18s rRNA between mock-infected and PrV-infected Hela cells 
is about 80% (Table 4.3.1).
4.4. Kinetics., of the decrease in incorporation during _ 
infection.
3The decrease in incorporation of H-uridine into 45s
pre-rRNA was examined at different times post-infection after
a 15 min labelling period. The 15 min labelling time period
3allows assesment of H-uridine incorporation levels into 45s 
pre-rRNA at a time when most of the label would be associated 
with the 45s pre-rRNA and it can be assumed that little 
processing to smaller rRNA species will have occured. However 
at this labelling period there will be synthesis of hnRNA and • 
peaks other than ribosomal precursor can be seen in the gels.
Nucleolar RNA was prepared as above from Hela cells, 
mock-infected or infected with PrV and labelled with H-uridine 
for a 15 min period before harvesting. Cells were harvested 
at 2 hrs,4 hrs and 6 hrs postinfection. The nucleolar RNA 
was subjected to electrophoresis in 2.7% acrylamide gels, 
Acrylamide gels were scanned for optical density in a Gilford 
Gel Scanner and radioactivity was estimated in 1mm gel slices 
cut with a Mickle gel slicer as described in Materials and Methods 
The specific radioactivity of 45s preGrRNA was calculated 
from the optical density and radioactivity profiles (Fig.4.4.1). 
Incorporation of H-uridine into 45s pre-rRNA drops gradually 
as the infection proceeds, reaching values as low as about 
40% at 6 hrs postinfection (Fig. 4.4.2),
4.5. Discussion
3As described above, incorporation of H-uridine into
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Figure 4.4.1. Optical density and radioactivity profiles
of nucleolar RNA separated on polyacrylamide 
gels.
Hela cells grown in Roux bottles were mock-infected or
infected with pseudorabies virus at a multiplicity of 50
pfu/cell. At 2 hrs, 4hrs and 6 hrs after infection cells
3 .were labelled with 5 pCi/ml H-uridine for a period of 15 min 
before harvesting. Nucleoli and nucleolar RNA were prepared 
as described for Fig. 4,2.1. Nucleolar RNA from mock-infected 
and infected cells was subjected to electrophoresis on 2.7% 
acrylamide gels as described in Materials and Methods.
Optical density was recorded in a Gilford gel scanner and 
radioactivity was determined in 1 mm gel slices as described 
in Materials and Methods,
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Figure 4.4.2. Specific radioactivity of newly synthesized
45s pre-rRNA.
The specific radioactivity of 45s rRNA was determined 
from the optical density and radioactivity profiles presented 
in Fig. 4.4.1.
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newly synthesized ribosomal RNA in Hela cells decreases after 
infection with pseudorabies virus. It is expected that minor 
differences in the number of cells or their growth state from 
culture to culture and therefore in the concentration of the 
labelling compound and possibly in the multiplicity of infection 
could hinder an accurate assesment of the decline in incorporation.
Even though a precise estimation is difficult, it is 
suggested that the values obtained give a reasonable estimation 
of the decrease in incorporation after infection.
As mentioned in the introduction, in order to assess the 
synthesis of RNA from the incorporation of H-uridine into RNA, 
the specific radioactivities acquired by the UTP pools after 
the pulse must be estimated. This is impossible to follow in 
these experiments due to the nature of the UTP pool responsible 
for ribosomal RNA. However, the assesment of the specific 
radioactivities of the UTP pools might not be of importance.
That is because the de novo synthesis of nucleotides in the 
UTP pool responsible for rRNA synthesis has been suggested, 
not to be subject to feedback inhibition by extracellular 
uridine to an appreciable extent (Wiegers et al., 1976) and 
even though possible changes in pool size after infection 
could not be ruled out, it is assumed that any difference 
in the specific radioactivities acquired by theseUTP pools during 
the labelling period, would not be too significant and therefore 
the decrease in the rate of synthesis would approximately 
follow the decrease in incorporation of H-uridine after 
infection. This could be seen from the similar decrease in 
RNA polymerase I activity in isolated nuclei of mock-infected 
and infected Hela cells (Chapter 7) where RNA synthesis is 
examined independently of the cellular UTP pools.
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Thus it is suggested that synthesis of 45s pre-rRNA of 
Hela cells after infection with pseudorabies virus undergoes 
at leaât a 40% reduction since later results suggest smaller 
UTP pool sizes in infected cells than in mock-infected and 
therefore more rapid equilibration of the precursor.
Furthermore, nucleolar area estimates (Chapter 3) approximately 
match these results again suggesting that the figures given 
here are a good indication of the virus effect on RNA 
synthesis despite the area of doubt concerning pool effects.
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CHAPTER 5. Processing of ribosomal RNA Hela cells after 
infection with pseudorabies virus.
5.1. Introduction.
Asidescribed in the Introduction (section, 1.1.2.2), 
formation of mature rRNA molecules involves (i) transcription 
of rRNA genes yielding pre-rRNA and (ii) maturation of pre-rRNA 
The process of maturation of pre-rRNA include;endonucleolytic 
cleavages of the newly synthesized pre-ribosomal 45s rRNA to 
yield the 28s and 18s mature ribosomal RNA’s.
It has been suggested that in herpesvirus infected cells 
a decrease in processing of 45s pre-rRNA occurs, describe as 
abortive, resulting in the degradation of 45s pre-rRNA into 
oligonucleotides sedimenting with S values of less than 18s 
(Wagner and Roizman, 1969 ). An inhibition of processing has
also been observed in vaccinia-infected L cells which has been 
interpreted as a slower rate of processing but not abberant 
processing. These authors have attributed the decrease in 
processing to the lack of one or more ribosomal proteins 
required for the formation of ribosomes (Jefferts &
Hollowczak, 1971).
5.2. Processing of 45 pre-rRNA in nucleoli of pseudorabies
virus infected Hela cells.
It has been suggested thatthe nucleolus contains all 
the early ribosomal RNA precursors (Penman et al., 1971) thus 
a study of the. early events in processing of the 45s pre-rRNA 
is best carried out using nucleoli rather than nuclei or 
cytoplasm.
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Therefore processing of 45s pre-rRNA was examined in 
phenol extracted nucleoli isolated from DNAse treated nuclei 
of Hela cells mock-infected ov pseudorabies virus infected.
Samples containing 1 O.D. unit of RNA were subjected
to electrophoresis on polyacrylamide gels as described in
Materialsand Methods. Ribosomal RNA was labelled with a 15 
3 .min pulse of H-uridine and chased with cold uridine and 
cytrdine in the presence of glucosamine for 30 and 60 minutes 
as described in Materials and Methods. Acrylamide gels were 
monitored after electrophoresis for absorbance and radioactivity 
and as shown in Fig. 5.2.1, 45s pre-rRNA is processed to 32s 
pre-rRNA, in the nucleolar extracts from the PrV-infected 
Hela cells as well as in the mock-infected Hela cells.
However, quantitation of this is difficult due to the lack of 
a standard RNA marker such as like 28s or 18s rRNA.
The high level of incorporation into 45s pre-rRNA seen 
at 4 hrs and at 6 hrs postinfection does not constitute a 
change in the rate of synthesis but rather an increaseti rate 
of incorporation due probably to the glucosamine used in the 
chase.
Glucosamine depletes already existing UTP pools. This 
could be seen in Fig. 5.2.2 where nucleolar RNA was extracted 
from mock-infected and PrV-infected Hela cells labelled for 
1 hr with ^H-uridine in the absence of glucosamine. The 
infected cells in this particular experiment show a decline in 
45s pre-rRNA radioactivity of about 60% to 70% compared to the 
mock-infected as would be expected from the results shown in 
Chapter 4.
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Fig. 5.2.1, Optical density and radioactivity profiles of 
nucleolar RNA pulse-labelled and chased, at 
4hrs and 6hrs after infection, then separated 
on polyacrylamide gels.
Hela cells grown in 80oz roller bottles were mocK-infect
or infected with PrV at 50 pfu/cell and labelled with lOpCi/ml 
3H-uridine for a period of 1$ min. The label was chased for 
30 min and 60 min with glucosamine and uridine as described 
in Materials and Methods. Nucleoli and nucleolar RNA were 
isolated as described for Fig, 4.2.1. and 1 O.D of nucleolar 
RNA was subjected to electrophoresis in 2.7% acrylamide gels 
as described in Materials and Methods. Optical density was 
recorded in a Gilford Gel Scanner and radioactivity was 
determined in 1 mm slice's as described in Materials and 
Methods.
O
— --------^  |h rv\
ControlRNANucleolar
Pulse at 4 hr after infection
Pulse at 6 hr after infection
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Fig. 5.2.2. Optical density and radioactivity profiles of
Kiock-lnfected or infected nucleolar RNA
OV\
separated/Npolyacrylamide gels at 6 hrs after- 
infection .
Hela cells grown in 80oz roller bottles were
mock-infected or infected with pseudorabies virus at 50 pf.u.
. 3 . .per cell and labelled with lOpCi/ml H-uridine for a period 
of 1 hr. Nucleolar RNA was prepared, subjected to electrophor 
and the optical density and radioactivity profiles were 
determined as for Fig. 5.2.1.
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5.3. Processing of newly synthesized ribosomal RNA in
pseudorabies virus infected whole Hela cell extracts. 
Processing of newly synthesized pre-rRNA was examined 
in extracts of mock-infected and PrV-infected whole Hela cells 
in order to follow the complete pathway of processing to 
mature ribosomal RNA.
Hela cells grown in Roux bottles were mock-infected or 
infected with PrV, labelled at 4 hrs and 6 hrs postinfection 
with a 15 min pulse of ^H-uridine and chased afterwards with 
cold uridine and cytidine in the presence of glucosamine for 
30', 60*’, or 120 minutes. Cells were harvested and whole cell 
RNA was phenol-extracted as described in Materials and Methods. 
Equal amounts of whole cell RNA samples were subjected to 
electrophoresis in 2.7% acrylamide gels, Acrylamide gels 
were scanned for optical density in a Gilford Gel Scanner and 
radioactivity was estimated in 1mm gel slices cut with a .. . 
Mickle gel slicer. Optical density and radioactivity profiles 
were determined for 4 hrs mock-infected and infected (Fig. 5.3,1) 
and 5 hrs mock-infected and infected Hela cells (Fig. 5.3,2).
It is clear that processing of the 45s pre-rRNA continues in 
the infected cells and radioactivity appears under the 28s and
i*8s peaks even as late as 7 hours after infection.
The total amount of radioactivity present at 30% 60% and
120 minutes under the main ribosomal RNA peaks was calculated
and after being corrected for the optical density of the 
prominent 28s and 18s peaks was expressed as a percentage of 
the initial amount of radioactivity of newly synthesized 
ribosomal RNA at 15 min both for 4 hr and 6 hr mock-infected 
and infected whole cell extracts. This is shown in Fig. 5,3.3,
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Fig. 5.3.1. Optical density and radioactivity profiles of
whole cell RNA pulsed and chased, at 4 hrs after
infection and separated on polyacrylamide gels.
Hela cells grown in Roux bottles were mock-infected or
infected with 50 p.f.u./cell and labelled with 5 p-.Ci/ml 
3 . .H-uridine for a period of 15 min. The label was chased for 
30', 60' and 120' with glucosamine and uridine as described in 
Materials and Methods. Whole cell RNA was phenol-extracted 
and subjected to electrophoresis in 2.7% acrylamide as 
described in Materials and Methods. Optical density and 
radioactivity profiles were determined as for Fig. 5.2.1.
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Fig. 5.3.2. Optical density and radioactivity profiles of
whole cell RNA, pulsed and chased, at 6 hrs
after infection and separated on polyacrylamide
gels.
The same procedure was followed as for Fig. 5.3.1.
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Fig. 5.3.3. Total radioactivity of individual ribosomal 
RNA species during the chase.
The sum of the radioactivities of the four main 
ribosomal RNA species was determined from the radioactivity 
profiles of figures 5.3.1. and 5.3.2.
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Fig. 5.3.4. Radioactivity of 45s and 32s rRNA during the 
chase.
The radioactivities of 45s and 32s rRNAs were 
determined from Figs. 5,3,1 and 5.3.2.
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Fig. 5.3.5. Radioactivity of 28s and 18s rRNA during the 
chase.
The radioactivities of 28s and 18s rRNAs were 
determined from Figs, 5.3.1. and 5.3.2,
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The decline of total radioactivity during the chase 
follows a similar pattern for both mock-infected and infected 
at 4 hrs and 5 hrs.
It has been found that the ratio of the optical density 
of the two stable ribosomal RNAs, 28s and 18s, appears to be 
the same in all of the geÿls the ratio being 28s; 18s= 1 : 0.5. / 
In addition it has been shown in this laboratory that there 
is no degradation of cytoplasmic rRNA at least in the first 
six hours of infection.
The decline of radioactivity in 45s pre-rRNA and 32s . 
pre-rRNA (Fig. 5.3.4) was expressed as a percentage of the 
initial amount of radioactivity under the 45s pre-rRNA peak 
at 15 min pulse. No difference could be found between 
mock-infected and infected Hela cells for 45s pre-rRNA. The 
32 pre-rRNA radioactivity was slightly increased in the 
infected cells.
In a similar way 18s and 28s (Fig. 5.3.5) radioactivity 
was calculated during the chase. There is a decrease in the 
radioactivity accumulated into 28s and 18s rRNA* s in the 
infected cells relative to the radioactivity in the 
mock-infected cells, i.e. whereas 18s accumulated 7% of 
initial radioactivity of 45s pre-rRNA in mock-infected Hela 
cells, it accumulated about 4% in the infected Hela cells.
The corresponding figures for 28s rRNA were 11% and 8% 
respectively.
5.4, Discussion
From the results presented in this chapter the processing 
of the newly synthesized ribosomal RNA appears to follow a 
similar pattern in the pseudorabies virus infected Hela cells
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to that of the mock-infected cells.
The glucosamine, chase was employed in these experiments 
as an alternative to the actinomycin chase because it does not 
affect directly RNA synthesis as actinomycin does, but affects 
the UTP pool size by trapping UTP in the form of UDP- N-acetyl 
- D- glucosamine (Fig. 5.4.1) which is later released. The 
glucosamine method was used to minimize possible side effects 
which could hinder the assesment of the processing taking 
place during infection.
The degradation of the newly synthesized 45s pre-rRNA 
into oligonucleotides with s values less than 18s which was 
mentioned in the introduction to this chapter does not appear 
to occur in the pseudorabies virus infected cells. The 
decline of the initial pulse of radioactivity into the newly - 
synthesized 45s pre-rRNA appears to be the same after the chase 
for both mock-infected and infected Hela cells, although there 
is an indication that processing is slowed down to some extent. 
This could be seen from the decrease in percentages of the 
initial radioactivity of 45s pre-rRNA which is later found 
in 18s and 28s of the infected cell.
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CHAPTER 6. On the association of newly sunthesized proteins 
with the nuclei of Hela cells infected with PrV.
6.1. Introduction
Herpesviruses induce quantitative and qualitative ■ . 
changes in protein metabolism in the infected cell,as described 
in the Introduction. Thus the rate of protein synthesis drops 
soon after infection, rises for a short period and finally 
and irreversibly declines in late infection. Qualitatively 
the synthesis of most of the host identified polypeptides is 
abolished after infection and the synthesis of new polypeptides 
identified as viral-specific is induced. It has been suggested 
that about 50 new polypeptides are induced after infection 
with HSV-1 (Honess and Roizman, 1973; Powell & Courtney,
1975; Marsden et al., 1976). Whereas Haarr and Marsden (1981) 
detected about two hundred and thirty virus-induced 
polypeptides in BHK cells infected with HSV-1 by means of two 
dimensional gel electrophoresis. Some polypeptides, visualised 
as a single band on a one dimensional SDS-polyacrylamide gel, 
were resolved into several spots.
Most of the newly synthesized, viral-induced polypeptides 
migrate to the nucleus of the infected cells (Fujiwara & Kaplan 
1967), Thus the major structural polypeptides have been shown 
to migrate to the nucleus (Courtney et al., 1971; Mark &
Kaplan,1971) where they are assembled into virus nucleocapsids 
(Olshevsky et al., 1967; Spear and Roizman, 1968; Ben-Porat 
et al., 1969)"While other, newly made polypeptides remain in 
the cytoplasm (Me Combs, 1974; Fenwick et al*, 1978). All of 
the immediate early polypeptides are transferred to the nucleus
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(Pereira et al., 1977).
Furthermore,it has been suggested that viral induced 
nuclear polypeptides show affinities for various constituents 
of host cell nuclei which are likely to determine their nuclear 
accumulation (Fenwick et al., 1978) and therefore their 
possible function. Indeed in BHK 21 cells which were infected 
with pseudorabies virus, 2 viral acid-soluble polypeptides 
were found to be associated with isolated chromatin (Chantier 
and Stevely, 1973) and a number of HSV-1 and HSV-2 specific, 
DNA-binding proteins have been identified by affinity 
chromatography on columns containing cellular DNA (Bayliss 
al., 1975; Powell & Purifoy, 1975; Purifoy & Powell, 1976). 
Immediate early proteins of HSV-1 and HSV-2, bind with a 
range of affinities to native calf thymus DNA in vitro and 
to chromatin from infected cells (Hay & Hay, 1980).
A further demonstration of the affinity of a viral 
induced polypeptide for a nuclear component, isr-.in the report 
of the association of ICP 4 of HSV-1 with an intranuclear 
body resembling the nucleolus at late times after infection. 
This protein was not found in association with nucleocapsids 
or enveloped particles (Cabral et al., 1980).
6.2. Association of newly synthesised proteins with the
Nuclei of Hela cells infected with pseudorabies virus.
Hela cells grown in 80oz roller bottles, infected with
pseudorabies virus at a multiplicity of 50 p.f.U. per cell and 
3 5labelled with S:-methioninefor 2hrs before being harvested 
at 2hrs, 4hrs and 6hrs after infection. Nuclei were isolated, 
treated with SDS, and subjected to electrophoresis in : 'DC-
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Fig. 6.2,1. Polyacrylamide gel electrophoresis of mock-infected
and infected Hela cell nuclectr . proteins.
Hela cells grown in 80oz roller bottles were mock-infected
or infected with pseudorabies virus at 50 pf.u. per cell and
35labelled with lOpCi/ml S-methionine for 2 hours before 
harvesting at 2 hrs, 4 hrs and 6 hrs after infection. Nuclei 
were isolated, dissolved in SDS-buffer and the solution was 
subjected to electrophoresis in 12.5% acrylamide gels as described 
in Materials and Methods. Molecular weight markers were run in 
parallel lanes.
Track a mock-infected
Track b 2 hrs infected
Track c 4 hrs infected
Track d 6 hrs infected
infected cell sreoific poljrpeMldes
1-24
#
■ . 160.000
■ . 68.000
. 33.000
» i
60fc
L35K
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Table 6.2.1, Approximate molecular weights of nuclear viral
induced polypeptides.
Approximate molecular weights of viral induded polypeptides 
at 2 hrs, 4 hrs and 6 hrs, were determined from Fig. 6,2.1.
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Nuclear Proteins
0-2h ' 2h-4h 4h-6h
^200k (1) A? 200k (1) ^^OOk (1)
135k (2) 135k (2)
130k (3) 130k (3)
87k (4) 87k (4)
69k (5)
42k (6) 42k (6) 42k (6)
36k (7)
33k (8)
' 31.5k (9)
30k ( 10)
29k (11) 29k (11) 29k (11)
28k ( 12) 28k (12) 28k (12)
26k (13)
13.5k ( 14)
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SDS-acrylamide thin layer slab gels, as described in Materials 
and Methods. Gels were dried and exposed to X-ray film.
About 14 new polypeptide bands appear in the nuclear 
fraction of infected cells, mostly at 4hrs to 6hrs after 
infection (Fig. 5.2.1, slot 4). About half of the bands 
appear at 2hrs to 4hrs (Fig, 6.2,1, slot 3) and 3 to 4 at 
Ohrs to 2hrs (Fig. 6.2.1, slot 2) after infection. The range 
of themolecular weights of the newly synthesized polypeptides 
is quite wide ranging from low molecular weight 13.5 K to the 
-200 K high molecular weight band (Table 5,2.1). Moreover a 
number of host polypeptides cease to appear at late times 
after infection, particulary the histones and low molecular 
weight polypeptides whereas there are other host polypeptide 
bands which appear in all of the samples.
6.3. Association of newly synthesized proteins with the
hhcleoli of Hela cells infected with pseudorabies virus.
Hela cells grown in 80oz roller bottles were infected
35with PrV , labelled with S-methionine and the nuclei
isolated as described above. Nucleoli were further isolated 
from the nuclear fraction by sonication and after treatment 
with SDS were subjected to electrophoresis in 9% or 12.5% 
acrylamide thin layer slab gels in SDS. Gels were dried 
under vacuum and exposed to X-Ray film as described above.
The autoradiographs produced (Fig. 5.3.1) show at all 
times a similar distribution of polypeptides to these 
obtained for the nuclear fraction but the number of polypeptides 
(Fig, 6.3.1, slot 3) that appear at 6hrs after infection is 
fewer than for the corresponding nuclear fraction, being
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Fig, 6,3.1. Polyacrylamide gel electrophoresis of mock-infected
and infected Hela cell nucleolar proteins.
Hela cells grown in 80oz roller bottles were mock-infected
or infected with pseudorabies virus at 50 pfu. per cell and
35labelled with lOjiGi/ml S-methionine for 2 hours before harvesting 
at 2 hrs, 4 hrs and 6 hrs after infection. Nucleoli were isolated 
by sonication as described in Materials and Methods and the 
proteins subjected to electrophoresis as for Fig. 6.2.1.
Gel A Gel B
Track a mock-infected Track a mock-infectec
Track b 2 hrs infected Track b 6 hrs infecte
Track c 4 hrs infected
Track d 6 hrs infected
infected cell specific polypeptides
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Gel A Gel B
,160k
.39k
i  a.
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Table 6,3.1. Approximate molecular weights of nucleolar viral
Ihduced polypeptides.
Approximate molecular weights of viral induced polypeptides 
at 2 hrs, 4 hrs and 6 hrs were determined from Fig, 6.3.1,
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Nucleolar Proteins
2h-4h 4h“6h Cycloheximide treated
(r200k) (1)
135k (2) 135k (2) 135k (2)
130k (3) 130k (3) 130k (3)
87k (4) 87k (4) 87k (4)
42k (6) 42k (5) 42k (6)
35k (7) 36k (7)
33k (8) 33k (8)
29k (11) 29k (11) 29k (11)
28k ( 12) 28k (12) 28k ( 12) '
26k (13)
13. 5k (14)
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Fig. 6. 3. 2. Polyacrylamide gel electrophoresis of
mock-infecteel and infected Hela cell nucleolar
proteins after treatment with cycloheximide.
Hela cells grown in OOoz roller bottles were mock-infected
or infected with pseudorabies virus at 50 p.f.u. per cell.
Immediately after infection cycloheximide was added to the medium
at a concentration of 50pg/ml for 4 hrs. Then medium was decanted
3 5and cells were labelled with 30)pZi/ml S-methionine for 1 hr. 
Nucleoli were isolated and their proteins subjected to 
electrophoresis in 9% and 15?/». , acrylamide gels as described in 
Fig. 6.3.1,
1
Gel A Gel B
Track a mock-infected Track a mock-infect
Track b infected Track b infected
infected cell specific polypeptides
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pig. 5.3.3. Two-dimensional polyacrylamide gel electrophoresis
of mock-infected and infected Hela cell nucleoli. .
Hela cells grown in 80oz roller bottles, were mock-infected
or infected with pseudorabies virus at 50 p.f.u. per cell and
I 3 5labelled with 50 p.Ci/ml S-methionine, from 1 hr to 6 hrs 
postinfection. The nucleoli were isolated by sonication and their 
proteins subjected to two-dimensional electrophoresis as described 
in Materials and Methods.
Gel A Gel B
mock-infected infected.
/ major cell specific polypeptides
\ ' major infected cell specific polypeptides
medium infected cell specific polypeptides
JL(c cm3.
6el A
Bocsic
105^  •
€dc. »
Ge\ B
1€6|l«
15SK
68K-
3SV..
&tsic C-Viot
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Table 6.3.2. Approximate molecular weights of nucleolar viral
induced polypeptides as resolved by 2-D gel 
electrophoresis.
Approximate molecular weights were determined from 
Fig. 6.3.3.
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Polypeptides in 2-D gels of nucleolar proteins.
0 r-200k (1) # 59k (15)
135k (2) Ù 52k (15)
• 130k (3) 49k (17)
123k (4) 42k (18)
120k (5) • 42k (19)
112k (6) 40k (20)
112k (7) 36k (21)
0 87k (8) e 33k (22)
Q 87k (9) e 33k (23)
72k (10) e 31k (24)
72k (11) # 31k (25)
0 72k ( 12) 26k (26)
72k (13) 23k (27)
0 60k ( 14) 20k (28)
# intense
o medium
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about 10 polypeptide bands. (Table 6.3.1).
In other experiments Hela cells grown in 80oz roller
bottles infected and mock-infected with pseudorabies virus
were incubated in the presence of cycloheximide for 4hrs and 
35labelled with S-methionine for Ihr after cycloheximide
release. They were harvested as described in Materials and
Methods. Samples were applied to wells in 9% and 12.5%
acrylamide thin layer slab gels in SDS. After electrophoresis
the gels were dried and autoradiographed (Fig. 6.3.2). About
8 new polypeptide bands appear in the infected cells after
this treatment with cycloheximide. (Table 6.3.1).
Nucleolar extracts were further subjected to two-
dimensional gel electrophoresis. Nucleoli were isolated from
Hela cells mock-infected and infected with pseudorabies virus
3 5and further labelled with S-methionine for a time period of 
6hrs and then harvested.
Two-dimensional gel elecrophoresis was performed according 
to the method of O'Farrell as described in Materials and 
Methods. The autoradiographs produced (Fig. 6,3.3) show a 
number of new minor polypeptide spots in the infected cells 
and some of the major polypeptide spots which appear at the 
one dimensional acrylamide gels. (Table 6.3.2).
6.4. Association of newly synthesized proteins with the 
nucleolar chromatin fraction of Hela cells infected 
with pseudorabies virus.
Hela cells were mock-infected and infected with
3 5pseudorabies virus, labelled with S-methionine for a 2hr 
time period from 4hrs to 6hrs postinfection. They were
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Fig, 6.4.1. Polyacrylamide gel electrophoresis of mock-infect
and infected Hela cell nucleolar chromosomal 
proteins.
Hela cells were grown in 80oz roller bottles and
mock-infected or infected with pseudorabies virus at 50 p.f.u,
35per cell. Cells were labelled with 5pCi/ml S-methionine for 
2 hrs before harvesting at 6 hrs postinfaction. Nucleolar 
chromatin fractions were isolated and their proteins subjected tc 
electrophoresis at S% and 1 %  gels as described in Materials 
and Methods.
Gel A Gel B
Track a mock-infected Track a mock-infecte
■ Track b infected Track b infected.
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Gel A
: 160p
. 6sk
.
1.41
Table 6.4.1, Approximate molecular weights of nucleolar
chromatin viral induced polypeptides.
Approximate molecular weights of viral induced polypeptides 
present in nucleolar chromatin were determined from Fig. 6.4.1,
Nucleolar Chromatin Proteins
135k (2)
130k (3)
87k (4)
36k (7)
33k Ç8)
26k (13) •
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Fig. 5.4.2. Non-equilibrium polyacrylamide gel electrophoresis 
(NEPHGE) of nucleolar chromosomal proteins of 
mock-infected and infected Hela cells.
Nucleolar chromatin fractions from Hela cells prepared as 
for Fig. 6.4.1. were subjected to non-equilibrium isolelectring 
focusing as described in Materials and Methods,
Gel A Gel B
Mock-infected Infected.
infected cell specific polypeptides
AciJilc
evioL.
B a .s \c .
ÔvidL.
68
Gel B
^cicLic
ev\cL.
&oL»ic
evicL
I
• 68K
• SLi.SK
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harvested and the nucleolar chromatin fraction was extracted 
from isolated nucleoli.
Nucleolar chromatin extracts were subjected to one 
dimensional gel electrophoresis and two-dimensional non­
equilibrium (NEPHGE) gel electrophoresis as described in 
Materials and Methods.
It can be seen from Fig. 6.4.1 that about 6 new 
polypeptides appear in the infected cells (Table 6,4.1). At 
least three of these appear to be basic proteins. (Fig. 6.4.2).
5.5. Uptake of mock-infected and PrV-infected polypeptides
by isolated Hela cell nuclei in vitro.
Fenwick et al., (1978) showed that HSV-1 virus labelled 
polypeptides could be taken up by nuclei in vitro. A similar 
attempt was made to determine whether pseudorabies virus 
polypeptides could be taken into,by isolated nuclei in vitro. 
Thus unlabelled crude nuclei from both mock-infected and 
infected Hela cells were incubated in cytoplasmic preparations 
obtained from labelled infected or mock-infected Hela cells.
The nuclei were then collected, washed w&th detergents, lysed 
and examined for the presence of radioactive virus polypeptides. 
15% to 20% of the total counts in the incubation mixture 
remained in the nuclei after treatment with detergent.
Subsequent treatments with NaCl and SDS reduced the number 
of counts attached to the nuclei. (Table 5.5.1) Gel 
electrophoresis of the washed nuclei revealed that most of 
the polypeptide bands of infected cells were taken up by the 
isolated nuclei with a few exceptions (Fig. 6.5.1.). Nuclei 
incubated in cytoplasmic preparation' from cycloheximide treated 
mock-infected and infected Hela cells show again all of the
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Table 6,'5.1. Uptake of radioactivity by unlabelled  ^ mock-infecte
or infected Hela cell nuclei incubated with
radioactively. labelled mock-infected and infected
Hela cell extracts.
Hela cells harvested at 5 hrs after infection of
mock-infection were suspended in 1 mM PO^ pH 7.4. and homogenised.
Sucrose was added to give an 0.25 M concentration and the
suspension wasspun at 1500 rpm for 10 min. The pellet is crude
nuclei and the supernatant is "cytoplasm**, 1 ml of appropiate
3 35cytoplasm labelled with H- or S-methionine was added to the 
pellet of nuclei, and mixed gently and incubated at 37^C for 30 
min. The suspension was spun at 1500 rpm for 10 min and the 
ensuing pellet of nuclei was washed three times with 1% Tween 80, 
extracted with 0.35 H NaCl and the residue was dissolved in 2%
SDS, 1% B-mercaptoethanol. Radioactivity was determined as 
described in Materials and Methods.
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Fig. 5.5.1. Polyacrylamide gel electrophoresis of
polypeptides from unlabelled uninfected nuclei
and nucleoli incubated in the presence of
radioactively labelled mock-infected and
infected Mela cell Cytoplasmic extracts.
Hela cells were grown in 80oz roller bottles to
confluency. Nuclei were isolated, after the cells were
allowed ? to swell in RSB and homogenized in a stainless steel
Dounce homogenizer. These crude nuclei were icubated with
cytoplasmic extracts from mock-infected and infected Hela
35cells which had been labelled with S-methionine.
Incubation was carried out at 30° for a period of 30 
min. Nuclei in the incubation mixture were pelleted and 
cleaned by treatment with mixed detergent as described in 
Materials and Methods. Nucleoli were prepared by sonication 
as described in Materials and Methods. The proteins of nuclei 
and nucleoli thus prepared were subjected to electrophoresis 
in 9% and 15% acrylamide gels as described in Materials 
and Methods,
Track a in mock-infected 
b in infected
l47oc
NUCLEI
: l&oic
.66%
I  fw
,3%K
«
M  CYCLOHEXIMIDE
! Traoc i t t d L  \
a t  a t
N U C L È O L I
“\
M Cvkclo\t«ximiiic\
>68%
39 K
.66K
39%
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polypeptides that appear in vivo. (Fig. 6.5.1).
Nucleoli were further isolated from the incubated nuclei 
and examined for radioactive virus polypeptides. Again most 
of the polypeptides found in vivo appear to have been taken 
up during the incubations in the cytoplasmic extracts, tFry 
(Fig.6.5.1),
356.6. Chase of S-methionine in nuclear and nucleolar proteins
of Hela cells after infection with pseudorabies virus.
Hela cells grown in 80oz roller bottles, were labelled 
35with S-methionine overnight and chased afterwards with a 
400-fold excess cold methionine when the cells were infected 
or mock-infected with pseudorabies virus. At 2hrs, 4hrs and 
6hrs after infection cells were harvested and nuclei were 
isolated and subjected to electrophoresis in acrylamide gels 
as described in Materials and Methods.
Figures 6,5.1 and 5.6.2 show the nuclear and nucleolar 
polypeptide pattern to be virtually identical for both 
mock-infected and infected and even the histones which cease 
to be synthesized after infection retain their label as late 
as 5hrs after infection at a time when synthesis of them 
practically ceases.
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Fig. 5,6.1. Polyacrylamide gel electrophoresis of nuclei
from mock-infected or-:, infected Hela cells 
radioactively labelled before infection.
Hela cells grown in 80oz roller bottles were labelled 
with 10 pci/ml of ^^S-methionine in the normal concentrati
of methionine in the medium. The cells were subsequently 
mock-infected or infected with pseudorabies virus at 50 p.f.u. 
per cell and the label was chased with a 400yfold excess of 
cold methionine during infection. Nuclei were isolated and 
their proteins subjected to electrophoresis as for Fig. 6,2.1.
Track a mock-infected
b 2 hrs infected
c 4 hrs infected
d 6 hrs infected
a l3 c cL 
%
160
. 1 1
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Fig. 6.5.2. Polyacrylamide gel electrophoresis of nucleoli 
from mock-infected or infected Hela cells 
radioactively labelled before infection.
Nucleoli were isolated by sonication from Hela cells 
prepared as for Fig. 6.6,1. and their proteins were subjected 
to electrophoresis in 9% and 12.5% acrylamide gels'as 
described in Materials and Methods.
Track a mock-infected
b infected
162,
a t
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6.7. Discussion.
From the results presented in this chapter it is clear
that viral-induced.-'polypeptides migrate into the nucleus of 
Hela cells as early as 2hrs after .infection, and the number 
of new polypeptides that appear into the nucleus increases 
as the infection proceeds.
Fewer polypeptides are isolated with the nucleoli, 
however the nucleolus does not appear to contain any 
viral-induced polypeptides which are absent from the rest of 
the nucleus.
About 28 viral-induced polypeptides were detected in 
nucleoli when two-dimensional gel electrophoresis was employed, 
as-characterized by both relative mobility following iso el^tric 
focusing and apparent molecular weight in SDS-polyacrylamide 
gels.
The (relatively) large number of polypeptides detected 
is due to the additional resolution afforded by two-dimensional 
gel electrophoresis which separates viral-induced polypeptides 
that co-migrate in one-dimensional SDS-polyacrylamide gels 
with more predominant host cell polypeptides and also 
separates into several spots viral-induced polypeptides which 
are visualized as a single band in one-dimensional gels.
These multiple spots at a single molecular weight may be 
related to modifications of single species such as 
phosphorylation, glycosylation (Haarr and Marsden, 1981) 
rather than distinct species.
Viral-induced polypeptides associated with the nucleolar 
chromatin fraction of Hela cells infected with pseudorabies 
virus number about six.
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Almost all of these six viral-induced polypeptides are 
taken up by isolated nuclei of uninfected cells in vitro when 
incubated with cytoplasmic extracts of Hela cells infected 
with pseudorabies virus. Furthermore most of them appear to 
be basic as is illustrated by non-equilibrium two-dimensional 
SDS-polyacrylamide gel electrophoresis (NEPHGE).
Nucleoli isolated from cyclohexmide treated Hela cells 
contain about eight viral-induced polypeptides which might 
include more than the immediate early species because the 
labelling time employed was relatively long. Polypeptides 
from the above cycloheximide treated nucleoli comprise four 
of the six viral-induced polypeptides isolated with the 
nucleolar chromatin.
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CHAPTER 7. DNA-depende.nt RNA polymerase activity in isolated 
nuclei of mock-infected and pseudorabies virus 
infected Hela cells.
7.1. Introduction.
That there is a decrease in ribosomal RNA synthesis 
after infection with herpesviruses has been suggested by the 
inhibition of incorporation of exogenous uridine into cellular 
RNA (Wagner and Roizman, 1969; Flanagan, 1964; Hay et al., 
1966).
A detailed analysis of this process in whole cells is 
hindered by the complexity of the uptake and metabolism of 
nucleoside triphosphates in cultured cells (Plageman, 1971 
a, b) , the possibility that there is a sepçûrate nucleotide 
pool responsible for ribosomal RNA synthesis (Wiegers et al., 
1976) and also by the effects of herpesviruses on other -, t. 
aspects of cellular metabolism, for example in protein 
synthesis.
The use of isolated nuclei to study transcription in 
infected cells provides a system in which RNA polymerase 
synthesis is almost completely dependent upon the addition 
of nucleoside triphosphates.
At least three DNA-dependent RNA polymerase activities 
(Blatti et al., 1970) have been detected by means of 
chromatography of nuclear extracts of eukaryotic cells.
These are, RNA polymerase I located mainly in the nucleolus 
and RNA polymerases II and III which are mainly nucleoplasmic 
(Roeder and Rutter, 1970). The fungal toxin ec-amanitin 
inhibits both RNA polymerase II and III at appropriate 
concentrations, whereas RNA-polymerase I is resistant to
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inhibition by a-amanitin.
It has been demonstrated that isolated nuclei from 
HSV-infected cells show decreased endogenous activity of RNA 
polymerase (Preston and Newton, 1976) which might be mediated 
by an inhibitor found in the herpesvirus-infected cells. This 
inhibitor was suggested to preferentially inhibit the nucleolar 
enzyme and to act by stopping chain elongation (Sasaki et al., 
1974.). Preston and Newton, 1976 further suggested that there 
was no transferable inhibitor of RNA synthesis detected when 
mixed nuclei of mock-infected and infected cells are assayed 
for RNA polymerase activity. However these conclusions are 
open to criticism Csee General Discussion).
7.2, a-Amanitin resistant RNA polymerase activity in the 
nuclei from mock-infected and infected Hela cells.
It has been suggested in Chapter 4 that ribosomal RNA 
synthesis in Hela cells declines after infection with 
pseudorabies virus. However, the processing of 45s pre- 
-rRNA is not greatly altered (Chapter 5). Because of the many 
problems involved in using the incorporation of H-uridine as 
a measure of RNA synthesis it was decided to employ an assay 
of RNA polymerase activity in isolated nuclei to examine 
further the decline of RNA synthesis during infection.
■Thus, Hela cells grown in 80oz roller bottles were 
mock-infected or infected with pseudorabies virus and harvested 
at 6 hours postinfection. Cells were allowed to swell in 
hypotonic buffer at 4°C,homogenized with a stainless steel 
D ounce homogenizer and nuclei were isolated by differential 
centrifugation and stored in aliquots at - 70°. Nuclei were
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Fig. 7.2.1. Total and a-amanitin resistant RNA polymerase
activities in isolated mock-infected and infected 
Hela cell nuclei at 6 hrs postinfection.
Hela cells were grown in 80qz roller bottles and 
mock-infected or infected with pseudorabies virus at 50 pf.u. 
per cell. Nuclei were isolated as described in Materials 
and Methods, RNA polymerase activity was determined in a 
200-pi reaction mixture at 25°C, a-amanitin resistant RNA 
polymerase activity was determined in the presence of 200pg/ml 
a-amanitin. At intervals, 10 pi samples were spotted onto 
Whatman No 1 paper discs, dried, washed in 10% cold TCA 
containing 1% pyrophosphate, washed in absolute alcohol and 
finaly in acetone. They were dried and radioactivity was 
determined in the presence of 1.0 ml toluene-PPO in a 
Beciunan scintilation counter 
Assay Mixture 
25 mM Hepes pH 7.5
12.5% glycerol
75 mM K Cl
5mM Mg acetate
0.4ïûM ATP
0.4mM GTP
0.4mM OTP
0,05 mM UTP
10 pCi/ml ^ H-UTP
a, without amanitin
b. with amanitin
eu
u
•H
CO
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assayed for RNA polymerase activity in a 200pl incubation 
mixture with or without a-amanitin as described in Materials 
and Methods.
Fig. 7.2.1 shows that there is a drop in RNA polymerase 
activity both in the absence and in the presence of a-amànitin 
for the nuclei from the infected cells compared with the nuclei 
from the mock-infected cells. Total RNA polymerase activity 
in the infected nuclei appears to be about 30% of that of the 
of the mock-infected nuclei whereas the a-amanitin resistant 
RNA polymerase activity in the nuclei from the infected cells 
is about 40% of that of the mock-infected nuclei. Under the 
conditions of assay the a-amanitin resistant activity is due 
entirely to RNA polymerase I.
7.3. RNA polymerase activity in the-presence of cytoplasmic 
extracts from mock-infected and infected Hela cells.
In the experiments described above it was shown that 
RNA polymerase activity in nuclei from infected cells is 
reduced compared with that in the nuclei from mock-infected 
cells. It has been shown in Chapter 6 that a number of newly 
synthesized viral induced polypeptides migrate into the nucleus 
and certain of them were found to.be associated with the 
nucleolus and nucleolar chromatin. These polypeptides were 
shown to be taken up by isolated nuclei in vitro.
In view of these results,experiments were carried out 
to examine whether incubation of cytoplasmic or whole cell 
extracts would in any way affect the RNA polymerase activity 
of the mock-infected or infected nuclei.
Thus nuclei from mock-infected or infected Hela cells 
were assayed for RNA polymerase activity after co-incubation
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Fig. 7.3.1. RNA polymerase activity of isolated mock-infected 
and infected Hela cell nuclei co-incubated with 
cytoplasmic extracts from mock-infected and 
infected Hela cells.
The RNA polymerase activity of nuclei from mock-infected, 
and infected Hela cell nuclei prepared as for Fig. 7,2.1. T/as 
determined in a 200-p.l incubation mixture at 25°C, in the 
presence of cell extracts prepared from mock-infected or 
infected Hela cells by sonication in salt solution for 5 min 
in an MSE sonifier, centrifugation for 15 min at 17k in a 
Sorvall rotor. 10 pi aliquots were spotted onto Whatman No 1 
papers and radioactivity was determined as for Fig. 7.2.1.
0 in mock infected cell extract, # in infected cell
extracts.
a. mock-infected nuclei
b, infected nuclei.
lot
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with cytoplasmic extracts from mock-infected and infected 
Hela cells prepared as described in Materials and Methods.
Assays were carried out in a 200pl incubation mixture at 
25*^ C and lOpl aliquots were spotted onto Whatman No 1 filter 
paper and radioactivity was determined as described in Materials 
and Methods.
Fig. 7.3.1 shows that there is rap drop in RNA polymerase 
activity in the mock-infected nuclei when they were co-incubated 
with the infected Hela cell extract, nor was there a rise in 
the infected cell nuclei co-incubated in the mock-infected 
Hela cell cytoplasmic extract.
Results were similar whether the RNA polymerase assays 
were carried out while the nuclei were still in the presence 
of the cytoplasmic extracts or after the nuclei had been 
redisolated.
7.4. Integrity of DNA in mock-infected and infected Hela cells.
A possible reason for the decrease in RNA synthesis after 
infection is that general or specific degradation of cell 
specific ENA might be induced by the virus. In an attempt 
to examine this possibility, DNA from mock-infacted and 
infected Hela cells was analysed on alkaline sucrose density 
gradients.
Hela cells grown in Roux bottles, labelled with
3 . . .H-thymidine overnight, were mock-infacted or infected with
pseudorabies virus, the label was chased during infection 
with excess cold thymidine. The cells were harvested at 6 
hours postinfection, lysed and applied onto 15% to 30% sucrose 
gradients. Gradients were centrifuged at 26k for 6 hours in a
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Figure 7.4.1 Radioactivity profiles of cellularDNA from 
mock-infected and infected Hela cells after 
centrifugation on alkaline sucrose density 
gradients.
Hela cells were grown in Roux bottles, and labelled 
with 5 pCi/ml of H-thymidine overnight. Cells were then 
mock-infected or infected with pseudorabies virus at 50 
p.f.u. per cell and the label was chased with excess cold 
thymidine for 6 hrs. Cells were then harvested and suspende 
in SSC. The suspension in SSC was pipetted into 0.3N NaOH, 
0,001M SDTA and 0.5% SDS, then layered onto 15% to 30% (w/\ 
sucrose gradients in 0.5M NaCl, 0.25N NaOH, O.OOII-: SDTA, 
0.01% oD3, The gradients were kept at room temperature for 
8 hrs",and then centrifuged at 25k for 6 hrs at 25° in a 
Bechman SW27 rotor. Radioactivity was determined in 1 ml 
fractions as described in Materials and Methods.
fO
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Beckman SW27 motor. They were harvested and radioactivity 
was determined after precipitation of the DNA onto glass 
fibre filter discs as described in Material and Methods.
The profile of cellular DNA (Fig. 7.4.1) appears to be 
similar both for mock-infected and infected Hela cells. No 
radioactivity accumulated at the top of the gradient in the 
case of the sample from infected cells which would have 
indicated degradation of the DNA.
7.5. RNA polymerase assay in the presence of sarkosyl.
It has been suggested that the detergent sarkosyl removes 
most of the proteins attached to the DNA template leaving 
only RNA polymerase- DNA template complexes and inactivates 
free RNA polymerase (Chesterton et al., 1975 ), It was shown 
above (Chapter 6) that viral induced polypeptides are 
associated with the nucleolar chromatin in infected cells.
These viral induced polypeptides might be the cause of the 
decrease in RNA synthesis, thus experiments were carried out 
to examine whether treatment with sarkosyl could restore the 
RNA polymerase activity in the infected cells.
Nuclei from mock-infected and infected Hela cells were 
assayed for RNA polymerase activity in the presence of 0.8% 
sarkosyl in an 80pi incubation mixture, as described in 
Materials and Methods.
Fig 7.5.1 shows that RNA polymerase activity in infected 
cell nuclei remained well below the level of the RNA polymerase 
activity of mock-infected cell nuclei. This could mean that 
there are fewer RNA polymerase molecules bound to the DNA 
template in infected cell nuclei than in the mock-infected
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Fig. 7.5.1. RNA polymerase activity of isolated mock-infected 
and infected Hela cell nuclei, in the presence 
of sarkosyl.
Nuclei from mock-infected and from infected cells were 
prepared as for Fig. 7.2.1, RNA polymerase activity was 
determined in an 80 pi incubation mixture in the presence 
of 0.8% sarkosyl. The reaction was stopped with 1% SDS,
ImM EDTA and TCA precipitable material was collected onto GF/C 
glass fibre discs. Radioactivity was determined as for Fig. 
7.2.1.
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Table 7,5.1, RNA polymerase activity of isolated raock-infected 
Hela cell nuclei co-incubated vrith cvtoplasmic 
extracts of luock-infecbed and infected Hela 
cells and treated vitli sarkosyl.
Nuclei from mock-infected Hela cells were prepared as 
for Fig. 7.2.1. Cell extracts of mock-infected and infected 
Hela cells were prepared as for Fig, 7.3.1, Nuclei were 
incubated with cell extracts in a 200 ul reaction mixture
without ^H-UTP for 15 min, at 25'^ C. Then 50 pi were 
transferred into 50 pi of an incubation mixture containing 
0,8% sarkosyl and H-UTP. The incubation was continued for 
a further 15 min. Reaction was stopped with 1% SDS, Imb! EDTA 
and radioactivity was determined as described in Materials 
and Methods.
In mock-infected 
cell extracts
In infected 
cell extracts
Percentage
of
radioactivity
100% 45%
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cell nuclei.
Next, a combination of co-incubation with cytoplasmic 
extracts for 15 minutes followed by treatment with sarkosyl 
for 10 minutes was carried out. This experiment showed a 
significant decrease in the RNA polymerase activity of mock- 
infected Hela cell'nuclei when incubated in an infected cell 
extract compared to the activity when- the■'mock-infected nuclei 
were incubated in the mock-infected cell extract(Table 7.5.1)
7.5. Discussion.
As described above, RNA polymerase activity in nuclei 
isolated from pseudorabies virus infected Hela cells is 
much lower than that of the mock-infected Hela cells, both 
for total and a-amantin resistant enzymeâ, which agrees with 
previous work (Preston and Newton, 1976) and the suggested 
decrease in ribosomal RNA synthesis described in Chapter 4.
In further attempts to investigate possible cause(s) 
of the decline in RNA polymerase activity after infection, 
assays were carried out in which the nuclei were co-incubated 
with cytoplasmic extracts and/or treated with sarkosyl, an 
agent known to strip off proteins from the DNA template.
Thus, isolated nuclei from mock-infected and infected 
Hela cells showed no difference when assayed for RNA 
polymerase activity both in the presence of mock-infected 
or infected cytoplasmic extracts, their RNA polymerase 
activity levels being similar to the non co-incubated nuclei.
RNA polymerase activity levels of infected Hela cell 
nuclei assayed in the presence of sarkosyl was not restored 
to normal, presenting a similar decline in RNA polymerase 
activity as with the non-treated with sarkosyl mock-infected
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and infected Hela cell nuclei.
However, mock-infected nuclei co-incubated with 
mock-infected or infected cytoplasmic extracts and assayed 
in the presence of sarkosyl showed RNA polymerase activity 
levels when co-incubated with infected cytoplasmic extract, 
of less than half the RNA polymerase activity when co-incubated 
with mock-infected cytoplasmic extract. This is fully 
discussed in the General Discussion.
In another line of experiments designed to examine the 
integrity of the DNA template, alkaline linear density sucrose 
gradients of mock-infected and infected Hela cell DNA which 
had been radioactively labelled before infection did not 
show any evidence of wholescale degradation after infection.
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CHAPTER 8. General Discussion.
It is now well established that infection of a number 
of cell lines with various animal viruses results in a 
marked inhibition in cytoplasmic ribosomal RNA production 
(see Nayak, 1977). In studies of this inhibition by many 
investigators it has been suggested that either the synthesis 
or the processing of ribosomal RNA both may be affected 
by the virus.
This study has examined the effect of pseudorabies 
virus on the nucleolar metabolism of Hela cells. The data 
of Chapter 6 suggest that pseudorabies virus inhibits the 
synthesis of ribosomal RNA. This is further supported by 
the decline in the total nucleolar area presented in Chapter 
3, as well as by the decline in RNA polymerase I activity of 
nuclei from pseudorabies virus infected Hela cells, described 
in Chapter 7.
In addition, the data on processing of ribosomal RNA, 
presented in Chapter 5,suggest that the processing of the 
newly synthesized ribosomal RNA of infected Hela cells^ 
though similar in pattern to that of the mock-infected 
Hela cells,is slower. On balance it appears that synthesis 
is more affected than processing.
Similar results have been reported for other viruses, 
though it appears that the level of inhibition of synthesis 
or processing varies, depending on the particular virus and 
possibly the cell line employed. Thus herpes simplex virus 
infection of HEp-2 cells results in the inhibition of both
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synthesis and processing of ribosomal RNA with the major 
effect on processing, which has been suggested to be abortive 
(Roizman et al, 1971).
In vaccinia virus infection of L cells, where both 
synthesis and processing are also inhibited, it has been 
reported that the processing of precursor rRNA and the rate 
of maturation of ribonu^leoprotein particles was slowed 
(Jefferts and Holowczak, 1971).
Similarly poliovirus and foot-and-mouth disease virus 
infection cause inhibition of the synthesis of 45s precursor 
RNA and a delay in the cleavage of this precursor (Darnell 
et al., 1967; Brown et al., 1966; Vande Noun de and Ascione, 1969 ) .
It has also been reported that the effect of vaccinia 
virus infection on synthesis and maturation of ribosomal RNA 
in mouse fibroblasts is more rapid than that for Hela cells 
(Becker and Joklik, 1964; Salzman et al., 1954; Oda and 
Joklik, 1967). The multiplicity of infection has also been 
shown to affect the rate of inhibition of synthesis and 
processing of ribosomal RNA (Roizman et al; 1971).
However, in discussing the effects of viruses on 
ribosomal RNA synthesis and processing,it must be borne in 
mind that they resemble those caused by inhibition of 
protein synthesis.
For example, it has been reported that inhibition of 
protein synthesis results in a reduced rate of 45s precursor 
rRNA processing and a reduction in the formation of ribosomes 
(Nillems et al., 196 8). Further it has been reported that 
cycloheximide, which inhibits protein synthesis by 99% , 
results within 60 seconds in a complete block of precursor
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rRNA processing (Udem and Warner, 1972) whereas when protein 
synthesis inhibition was only partial the inhibition of 
processing was less complete (Pederson and Kumar, 1971).
In view of the well established inhibition of protein.ug 
synthesis by many viruses one cannot exclude the possibility 
that the effect on inhibition of processing by viruses might be 
a result of protein synthesis inhibition.
This seems a reasonable explanation in view of the 
significance of proteins in the maturation of ribosomal RNA. 
Thus cleavage enzymes, methylases and ribosomal proteins are 
all at various stages associated with the ribosomal RNA. The 
possibility exists then that a depletion in the amount of 
any of these proteins might affect the normal processing of 
the pre-rRNA in virus-infected cells.
Therefore it might be expected that a decrease in the 
rate of processing of ribosomal RNA would vary between viruses, 
depending upon their efficiency in the shut-off of host protein 
synthesis. It has been reported that HsV-2 shuts-off host 
protein synthesis extensively at 90 minutes after infection 
and HSV-1 has a similar effect at 3.5 to 4 hours post-infection 
(Pereira et al., 1977). It remains to be seen whether HSV-2 
reduces processing more rapidly than HSV-1.
When considering general effects of reduced protein 
synthesis it is of interest,that there has been a suggestion, 
that the reported concomitant inhibition in ribosomal RNA 
synthesis is due to failure to synthesize a rapidly turning 
over transcription factor (Muramatsu et al., 1970; Franze 
Fernantez and Fontanive-Sanguesa, 1975). However it has been
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proposed that levels of cellular ATP and GTP are critical 
for ribosomal RNA synthesis and that there is no need to 
postulate a special transcription factor (Grummt and Grummt, 
1976). Clear evidence for such (a)-short lived protein(s) has 
not yet been provided.
Despite these remarks on the effect of protein synthesis 
inhibition,the data of Chapter 6 open the possibility that 
there is virus-mediated . inhibition of ribosomal RNA synthesis, 
by viral-induced proteins which are found to be associated 
with the nucleolus and the nucleolar chromatin of pseudorabies 
virus infected Hela cells. A role for viral-induced inhibition 
of ribosomal RNA is quite attractive, and . has been 
suggested by other investigators (Sasaki et al., 1974;
Preston and Newton, 1976).
As far as the mechanism of inhibition of ribosomal RNA 
synthesis is concerned,it has been reported that RNA polymerase 
I levels in HSV-1 infected BHK-21 cells remain virtually the 
same up to 8 hours after infection (Lowe, 1978)-however a 
decrease has been observed in RNA polymerase I activity after 
infection of RK cells with the same virus. (MUller et al., 
1978). It is possible that this discrepancy might be a result 
of the different extraction and assay procedures and cell 
lines employed.
However inhibition of rRNA synthesis might occur by 
interference with the template, possibly by viral induced 
degradation of the template or by the interference in the 
normal events of transcription by viral induced factors.
The data in Chapter 7 suggest that host ENA in infected cells 
is not affected or at least that the host DNA is not 
nonspecifically degraded. Similar findings have been reported
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by other investigators (FrancKe, 1977).
As far as interference with the DNA template is 
concerned, electron microscopic studies on nucleolar 
morphology in herpesvirus infected cells (Sirtori and Bossisio- 
Bestetti, 1967) indicated that changes in the nucleolar 
ultrastructure i.e. segregation of nucleolar components, 
resemble those of a suggested pattern of ultrastructural 
changes induced when ribosomal RNA synthesis is affected by 
agents which interact with the DNA template (Shinozuka, 1973).
Possible candidate(s) for this inhibitor could be the 
viral-induced polypeptides which migrate into the nucleus.
Many herpes induced proteins are known to have DNA-binding 
properties. Proteins associated with the nucleoli and nucleolar 
chromatin in pseudorabies-virus infected Hela cells are 
described in Chapter 6.
It has been assumed that the putative inhibitor is not 
transferable (Preston and Newton, 1976) which partly agrees 
with the results in Chapter 7 where the RNA polymerase 
activity of mock-infected cells appeared hot to be affected, 
when nuclei were incubated in infected cell extracts. That 
viral-induced polypeptides migrate into the incubated nuclei 
in vitro was shown in Chapter 6.
However, the relatively short time period and the 
conditions of assay employed were such that it would not be 
certain that the effect of an inhibitor could be registered 
and thuS whether it is transferable or not cannot be 
conclusively assumed.
An additional complication is that in most systems,
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the RNA polymerase activity registered is thought generally 
to represent completion of already initiated polynucleotide 
chains.
Thus, it could only be concluded that the inhibitor 
does not interfere with transcription at the elongation 
level of the polynucleotide chain, which is in contrast with 
a previously reported action of th is  inhibitor (Sasaki et al., 
1974). However, this suggestion is open to criticism on 
account of the template used in their study. The calf thymus 
DNA employed, due to methods of preparation, is likely to 
have present nicks and single strand regions which would 
favour the initiation of new RNA polynucleotide chains.
Thus the effect of the inhibitor could be either on initiation 
or elongation.
The finding that indicates that the effect of the 
inhibitor might be at the initiation level rather than that 
at elongation,comes from the data on sarkosyl treatment of 
mock-infected and infected nuclei described in Chapter 7.
It has been shown that although transcription is blocked 
in eukaryotic mitotic chromosomes,RNA polymerase remains 
bound. Transcription can be reactivated by removing 
chromosomal proteins with thedetergent sarkosyl which does 
not affect bound RNA polymerase (Carriglio, 1975).
RNA polymerase activity in mock-infected and infected 
cells was tested to find out whether or not transcriptional 
activity can be restored to normal with sarkosyl treatment,
A positive result would mean that enzyme remained bound to
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the template at a time that rRNA synthesis was inhibited. A 
negative result must indicate that synthesis is inhibited by 
a mechanism which prevents the enzyme from initiating.
In these experiments the difference in RNA polymerase 
activity in isolated nuclei is not changed from similar 
experiments without sarkosyl. This suggests that in infected 
cells fewer RNA polymerase molecules are in the form of the 
sarkosy^resistant RNA polymerase-DNA template transcriptional 
complexes.
Interference in the initiation of new stable transcriptional 
complexes could be concluded from the data presented in 
Chapter 7 where RNA polymerase activity was examined after an 
initial incubation in cytoplasmic extracts in vitro. These 
activities were determined in the presence of sarkosyl.
The rationale behind this experiment is that if an effect 
of the incubation of mock-infected nuclei in infected cell 
cytoplasmic extracts cannot be detected,due to the problem 
of the assay conditions, the combined assay with sarkosyl 
would enable an examination of transcription, a step earlier.
The possible formation of transcription complexes between 
RNA polymerase and DNA template cannot be excluded in an assay 
of RNA polymerase activity of isolated nuclei even though it 
would be difficult to detect, but when sarkosyl is used it 
would be expected that any differences in that level (due 
here to the incubation of nuclei in mock-infected or infected 
cytoplasmic extracts) could now be detected,due to the removal 
of the chromosomal proteins,which would allow bound but not 
actively transcribing RNA polymerase molecules to transcribe.
The RNA polymerase activity in mock-infected nuclei 
incubated in infected cell cytoplasmic extracts was shown to
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be lower than that of the mock-infected nuclei pre-incubated 
in mock-infected cytoplasmic extracts.
This suggests the presence in the cytoplasmic extract of 
infected cells of a factor(s) which affects the amount of RNA 
polymerases bound to the template and further that inhibition 
at the initiation level could'be the cause of the decrease in 
RNA synthesis. This could be due to one of the viral 
polypeptides shown to be associated with the nucleolar chromatin 
Confirmation of this requires experiments using purified 
viral-induced proteins and more stringent conditions of assay.
This suggestion would not fit with the model for a single 
promoter being responsible for the transcription of multiple 
ribosomal genes linked in tandem (Perry et al., 1970).
However recent findings about the existence of promoter sites 
for each individual ribosomal gene at the spacer regions 
(Scheer et al., 1975; Hackett and Sauerbier, 1975) seem more 
attractive and would support the above proposed mechanism.
Thus, according to these results we could form the 
following hypothesis. Viral-induced proteins in infected cells 
are attached to/or compete for the same sites in the DNA 
template which are used by RNA polymerase molecules for 
initiation.
Evidence for the validity of this hypothesis would come 
by defining further the viral induced proteins .in cell extracts. 
Purification and identification of individual proteins would 
allow a check on their effect on the RNA polymerase activity 
of isolated nuclei or nucleoli with or without sarkosyl.
Further evidence for their function as DNA binding 
proteins could be provided by incubation in vitro with 
nucleolar chromatin or naked cell DNA. Possible binding
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specificity could be provided by co-incubation with plasmids, 
containing rDNA and employing the filter retention technique. 
Restriction endonuclease fragments of rDNA might be further 
used.
Another line of experiments would be to examine possible 
virus proteins effects on RI\A synthesis using plasmids 
containing rDNA and employing purified RNA polymerase I.
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